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 Carbapenem resistance is a growing public health threat, leaving few treatment options 
for Gram-negative bacterial infections. The rise in community-acquired carbapenem-resistant 
infections is particularly alarming, and recent evidence indicates that drinking water may serve as 
a source of these organisms. Furthermore, there is concern that drinking water distribution 
systems may also amplify resistant organisms as a result of horizontal gene transfer of resistance 
genes within water distribution system biofilms. 
Current methods for testing and monitoring drinking water for the presence of 
carbapenem-resistant organisms can be expensive, cumbersome, or require special expertise, 
and are not ideal for low-resource countries. This work sought to develop and validate a simple, 
cost-effective method for screening for carbapenem-resistant organisms in drinking water. A 
fluorogenic substrate was combined with various concentrations of meropenem and vancomycin 
antibiotics using known carbapenem-resistant and susceptible strains of bacteria. The bacterial 
strains were used to generate artificially contaminated tap water samples in the laboratory to 
determine if the combination and concentrations were ideal in selecting for the target organisms. 
The method was able to select for low numbers of resistant organisms while suppressing non-
target tap water organisms. The method was then used to screen 19 samples from New Delhi, 
India. The method successfully identified eleven organisms clinically resistant to carbapenem 
antibiotics in seven samples. 
This work also explored whether or not carbapenem resistance factors can transfer within 
biofilms similar to those that exist in water distribution systems. Clinical donor strains carrying the 
blaNDM carbapenem resistance gene were used to transfer the gene to an E. coli intermediate by 
conjugation. The E. coli was then used to donate the blaNDM gene in both broth and biofilm 




systems. Transfer of the blaNDM gene to P. aeruginosa was not seen in broth, but was observed in 
biofilm after a 72-hour incubation of the donor and recipient organism. This indicates that the 
blaNDM carbapenem resistance gene may be able to transfer within drinking water distribution 
system biofilms, and biofilms may serve as a source of blaNDM amplification and increased 


































TABLE OF CONTENTS 
ABSTRACT ...................................................................................................................................... iii 
LIST OF TABLES ........................................................................................................................... vii 
LIST OF FIGURES ........................................................................................................................ viii 
ACKNOWLEDGEMENTS ................................................................................................................ ix 
Chapters 
 
1    INTRODUCTION ................................................................................................................ 1 
Introduction ......................................................................................................................... 1 
Specific Aims ...................................................................................................................... 8 
References ......................................................................................................................... 9 
2    DEVELOPMENT AND EVALUATION OF A METHOD FOR DETECTING  
CARBAPENEM-RESISTANT BACTERIA IN DRINKING WATER .................................. 15 
Abstract ............................................................................................................................. 15 
Introduction ....................................................................................................................... 15 
Methods ............................................................................................................................ 17 
Results .............................................................................................................................. 22 
Discussion ........................................................................................................................ 34 
Acknowledgments ............................................................................................................ 37 
References ....................................................................................................................... 37 
3    INFLUENCE OF NUTRIENT CONCENTRATION ON TRANSFER  OF THE BLANDM 
GENE INTO PSEUDOMONAS AERUGINOSA ............................................................... 41 
Background....................................................................................................................... 41 
Methods ............................................................................................................................ 43 
Results .............................................................................................................................. 46 
Discussion ........................................................................................................................ 49 
Acknowledgements .......................................................................................................... 51 
References ....................................................................................................................... 51 
4    TRANSFER OF THE BLANDM GENE TO PSEUDOMONAS  AERUGINOSA UNDER 
BIOFILM CONDITIONS .................................................................................................... 53 
Abstract ............................................................................................................................. 53 
Background....................................................................................................................... 53 
Methods ............................................................................................................................ 55 
Results .............................................................................................................................. 58 
Discussion ........................................................................................................................ 61 






5    CONCLUSION .................................................................................................................. 72 










LIST OF TABLES 
2.1.  Average MPN and Percent Recovery in Sterile Deionized Water after 48-Hour 
Incubation ......................................................................................................................... 23 
2.2.  Average MPN after 48-Hour Incubation with no Antibiotic, Meropenem only, and 
Meropenem with Vancomycin in Tap Water ..................................................................... 25 
2.3.  Effect of Incubation Time on MPN Count at 24, 48, and 72 Hours in Spiked Deionized 
Water Samples ................................................................................................................. 27 
2.4.  Effect of Incubation Time on MPN Count at 24, 48, and 72 Hours in Spiked Tap 
Water Samples ................................................................................................................. 29 
2.5.  Number of Positive 100 mL Presence/Absence Bottles from Triplicate Replicates 
after 48 Hours Incubation ................................................................................................. 30 
2.6.  Identification and Meropenem Minimum Inhibitory Concentrations of Organisms 
Isolated from Drinking Water Sites in New Delhi, India .................................................... 32 
2.7.  Antibiotic Disk Zones of Inhibition for Selected Isolates Recovered from Drinking 
Water ................................................................................................................................ 33 
3.1.  Conjugation Frequencies of NDM-Carrying Donor Strains into Azide-Resistant J53 E.  
coli at 30 Degrees and 37 Degrees C Expressed as Number of Transconjugants per 
Recipient ........................................................................................................................... 47 
3.2.  Minimum Inhibitory Concentrations of Donor, Recipient, and Transconjugant Strains 
as Determined by Etest .................................................................................................... 48 
4.1.  Conjugation Frequencies of NDM-Carrying Enterobacteriaceae Strains into Azide-
Resistant J53 E. coli at 30 Degrees and 37 Degrees Celsius Expressed as Number 
of Transconjugant per Donor Cell .................................................................................... 59 
4.2.  Conjugation Frequencies of J53-NDM Transconjugants into Rifampin- Resistant 
Pseudomonas at 30 Degrees Celsius by Broth Nutrient Concentration and Biofilm 
Growth Time Expressed as Number of Pseudomonas NDM Transconjugants per 
Donor Cell ......................................................................................................................... 60 
4.3.  Minimum Inhibitory Concentrations of Donor, Recipient, and Transconjugant Strains 










LIST OF FIGURES 
3.1. Sequence of experimental procedures ............................................................................. 44 
4.1.  Inverted gel of Pseudomonas isolates testing positive for the blaNDM gene by PCR. 
Brth = Broth. Bflm =Biofilm. Neg = Negative. Ctrl = Control ............................................. 62 
4.2.  Agarose gel of E. coli PCR ............................................................................................... 63 
4.3.  Agarose gel from Pseudomonas PCR ............................................................................. 64 
4.4.  Meropenem minimum inhibitory concentration Etest for blaNDM Pseudomonas 











This work was primarily funded by grants from the Health Studies Fund of the 
Department of Family and Preventive Medicine of the University of Utah.  Student support was 
also received from a Graduate Research Fellowship award from the University of Utah Graduate 
School. 
I am grateful for the help of Dr. Mark Toleman in supplying the necessary bacterial strains 
for my conjugation experimental work. I also appreciate the Utah Public Health Laboratory, the 
laboratory of Dr. Ramesh Goel, and Amity University Institute of Virology and Immunology for 
kindly allowing me to use their laboratory facilities for my research. 
I would especially like to thank my committee members, Drs. Jim VanDerslice, Christy 
Porucznik, Scott Benson, Ramesh Goel, and Robyn Atkinson, for their direction and assistance 
throughout the dissertation process. I would like to acknowledge and give special thanks to my 
mentor, Dr. Jim VanDerslice, for his encouragement, support, and guidance in the completion of 
my project, for contributing part of his own development funding toward my project, and for his 
confidence in my success. 
I also appreciate the many friends and family members for their support and 
encouragement throughout the entire process of my PhD research and education. I especially 
want to express gratitude to my husband, Jason, for his moral support, encouragement, and 













Antibiotic resistance is a critical and emergent public health challenge. As a result of 
improved sanitation, water treatment, infection control measures, and antimicrobial treatments, 
infectious disease has long been perceived as a public health problem that has been solved [1]. 
However, the emergence and global spread of many antibiotic-resistant organisms, including 
multidrug-resistant and totally-drug-resistant organisms, is creating untreatable infections, once 
again making infectious disease a relevant emergency, and no longer a future concern. In the 
United States alone, it is conservatively estimated that at least 23,000 deaths are attributable to 
antibiotic resistance each year [2]. The economic consequences of antibiotic resistance are 
staggering, costing the U.S. health system tens of billions of dollars and an estimated fall in U.S. 
real gross domestic product of 0.4 to 1.6% [3]. Globally the impact is thought to be much more 
severe, particularly in areas where infectious disease and antibiotic use are rampant, and where 
infectious disease prevention measures, such as sanitation and clean drinking water, are 
inadequate [3].  
Antibiotic resistance of any type may result in longer treatment times, increased medical 
costs, and increased morbidity and mortality [4]. Many antibiotic-resistant organisms can still be 
treated using an antibiotic to which the organism is still susceptible; however, some organisms 
are resistant to multiple classes of antibiotics, including some of the most powerful antibiotics 
available. Carbapenem antibiotics are considered last resort drugs, as they are used to treat 
infections with organisms that are already multidrug-resistant [5]. When bacteria acquire 
resistance to carbapenem antibiotics, few--if any--treatment options are available, and the 
treatments that are available are associated with increased morbidity and mortality [6-8]. Mortality 




global regions have reported carbapenem-resistance in as much as 55% of all bacterial isolates 
[3]. 
In Gram-negative bacteria, carbapenem resistance is usually mediated by one or more of 
three mechanisms: a) modification of the outer membrane proteins (OMPs), excluding entry of 
the carbapenem into the cell, b) upregulation of efflux pumps, exporting the antibiotic out of the 
cell, and c) production of a carbapenem-hydrolyzing β-lactamase [10]. Of the three Ambler 
classes of carbapenem-hydrolyzing-β-lactamases (carbapenemases): Class A, or clavulanic-
acid-inhibited carbapenemases, including the KPC genes [11], class B metallo-β -lactamases 
(MBLs) including the VIM and IMP genes, and class D OXA carbapenemases or oxacillinases, 
MBLs are considered more molecularly diverse than any other class of carbapenemases [10].  
In 2008, a new type of MBL antimicrobial resistance gene, designated New Delhi metallo-
β-lactamase-1 (NDM-1), was discovered in strains of bacteria believed to have originated from 
India [12]. Since the discovery of NDM-1, eight variants of the enzyme have been reported (NDM-
1 to -8), each with only single or double amino acid substitutions within the NDM enzyme [13]. 
These enzymes are collectively known as NDM-producers, encoded by blaNDM-like genes and are 
hereafter referred to as NDM-producers or the blaNDM gene. Between 2006 and 2012, nosocomial 
and community-acquired antibiotic-resistant infections involving bacteria containing the NDM 
gene have spread from India to over forty countries including the United States, with a crude 
mortality rate of 23.8% among those infected and 10.3% among those colonized but not infected 
[14](Johnson and others). NDM is a very serious concern as 1) the gene codes for resistance to 
carbapenem antibiotics, which are considered the last line of defense for many infections [5, 12], 
2) molecules of DNA carrying the blaNDM gene tend to “collect” other antimicrobial resistance 
genes [10], 3) some bacteria carrying these collections of resistance genes appear to be 
completely resistant to all classes of antibiotics [10]. NDM-producers have been recovered from 
both clinical and environmental samples, carried by both pathogenic and nonpathogenic 
organisms [15-18]. Concerns about community-acquisition of the blaNDM gene, coupled with 
detection in the environment, including in drinking water supplies, raise concerns about the role of 
raw and treated water supplies in disseminating organisms carrying the blaNDM gene and other 




Antibiotic-resistant bacteria and antibiotic-resistant genes (ARG) have been isolated from 
various water environments in many countries, with many organisms exhibiting multiple drug 
resistance [15, 19-29]. Antibiotic-resistant bacteria, including carbapenem-resistant organisms, 
are commonly found in both raw and treated wastewater [30-34]. Hospital wastewater, in 
particular, is a major source of antibiotic-resistant bacteria and ARGs in the environment [30, 33, 
35-37]. Wastewater from five hospitals in Beijing all contained CRB, with four also showing 
evidence of the NDM-1 gene [36]. Pathogenic antibiotic-resistant bacteria, or nonpathogenic 
bacteria carrying transferrable ARGs, present in treated or untreated wastewater or in natural 
waters, can eventually migrate into aquifers used for drinking water, or into surface waters 
supplying a water treatment plant [30-32]. Drinking water treatment processes do not remove 
ARG from source waters [27, 38, 39]. Xi et al. found that even when nonpathogenic heterotrophs 
(i.e., HPC bacteria) were reduced 10,000-fold, there was only a 10-fold reduction in ARG [38]. 
Certain types of water treatment may actually increase the proportion of multiple antibiotic-
resistant bacteria by creating selective pressure that favors the resistant bacteria [27, 40, 41].  
A variety of antibiotic-resistant bacteria have been found in treated drinking water [26-28, 
38, 42-45]. In the early 1990s, Gaur et al. found that over 90% of the thermotolerant (fecal) 
coliforms isolated from drinking water in rural India had single (13.7%), double (48.6%), or 
multiple (31.4%) antibiotic resistances and many of these bacteria were capable of transferring 
antibiotic resistance to an E. coli recipient [44]. Recently, antibiotic-resistant heterotrophic plate 
count (HPC) bacteria were isolated from source, finished, and tap waters in several U.S. cities 
[38]. In some U.S. tap water samples, over 80% of the HPC bacteria were resistant to at least a 
single antibiotic [38]. Researchers in Beijing, China, examined 50 samples from treated water 
supplies and found no organisms carrying the NDM-1 gene [36]. High levels of carbapenem 
antibiotic used in this study to isolate the carbapenem-resistant organisms (10 µg/mL imipenem) 
may have inhibited some carbapenem-resistant organisms. Walsh et al. analyzed 50 New Delhi 
tap water samples and found that 28% contained organisms that grew on media containing a 
carbapenem antibiotic, and that 4% of the samples had bacteria harboring the NDM-1 gene; the 
authors commented that this may be an underestimation of the prevalence of NDM-1 due to long 




nonpathogenic bacteria commonly found in tap water throughout the world [15, 46]. However, the 
researchers were able to demonstrate transfer of the blaNDM gene from many of the 
nonpathogenic heterotrophs isolated from seepage samples to E. coli and other pathogenic 
organisms [15]. Studies have also demonstrated that antibiotic resistance genes can be 
transferred from such nonpathogenic bacteria to pathogens in the human gut [47-49]. The results 
from the Walsh study indicate a potential for transmission of the blaNDM gene to large segments of 
the population via bacteria that are not the target of conventional drinking water treatment, nor 
subject to water testing under current regulations [15, 50].  
The demonstration of the horizontal gene transfer (HGT) of the blaNDM gene to other 
genera of bacteria also indicates a potential for horizontal gene transfer in the environment. HGT 
occurrence in aquatic environments is well documented [51-53], which enhances the movement 
and persistence of ARGs through residence in a wide variety of bacteria [32, 54, 55]. HGT has 
been observed in wastewater treatment systems, surface water and groundwater, as well as 
drinking water distribution systems [32, 56]. Some studies have observed increases in the 
proportion of bacteria that are antibiotic-resistant after wastewater treatment [57, 58]. As a result, 
aquatic environments are thought to be important “mixing pots” for ARG; however, research on 
this topic is limited [59, 60].  
Biofilms are a unique microenvironment believed to facilitate HGT [32, 60, 61]. Biofilms 
form on virtually every surface in contact with both treated and untreated water, including the inner 
surface of treated water distribution system pipes [62].
 
They play an important role in the 
persistence and propagation of antibiotic-resistant bacteria and ARG in aquatic systems [32, 38, 
45, 54, 63, 64].
 
They harbor diverse species of microorganisms, including pathogens and HPC 
bacteria [65, 66].
 
Biofilms in drinking water systems are suspected to be the primary source of 
waterborne microorganisms in intact, well-operated drinking water systems [66-68]. 
Biofilm provides fixed contact between bacteria creating the ideal setting for HGT by 
conjugation [60, 69]. Organisms can move between water and biofilm, thus increasing their 
residence time in the distribution system. As biofilms offer protection from disinfectants [45],
 
antibiotic-resistant bacteria within biofilms are expected to survive for longer periods of time, 
increasing the probability of successful HGT [45].
 




dramatically in the presence of biofilm [70].
 
In one study, investigators recovered bacteria 
containing ARGs in biofilms from hospital wastewater, treated wastewater, a river receiving the 
treated wastewater, water from that river coming into the treatment plant, and water in the 
distribution system [32].
 
They found that while few of the organisms detected in wastewater were 
present in distribution system biofilm, the same ARGs from the wastewater were found in the HPC 
bacteria isolated from the drinking water biofilm. When Walsh et al. sampled drinking water 
sources in New Delhi, one of the two samples in which NDM was detected, had three organisms, 
all from different genera, that carried the blaNDM gene [15]. This may suggest horizontal gene 
transfer of the blaNDM gene within the aquatic environment. Other reports have suggested that 
hospital outbreaks of NDM infections may be attributed to transfer of the blaNDM gene within 
biofilms in the hospital sinks [71-73]. 
In the study by Walsh et al., multiple genera and species of bacteria were found to be 
carbapenem-resistant and/or to carry the NDM-1 gene, including Pseudomonas and Aeromonas, 
which are common HPC bacteria ubiquitous in tap water [15, 46]. Pseudomonas and Aeromonas 
have been found in 2-3% and 1-27% of tap water samples, respectively [74]. Pseudomonas is 
known to frequently form biofilms, and horizontal gene transfer of resistance factors to and from 
Pseudomonas species has been demonstrated, including in biofilms [55]. Consequently, 
Pseudomonas could play a role in intergenus transfer of antibiotic resistance genes in aquatic 
environments, including the blaNDM gene. 
Though the most severe impact of antibiotic resistance appears to be on the other side of 
the globe, the United States is not immune from the impacts of antibiotic resistance, even 
carbapenem-resistance. Presently it is estimated that there are at least 9300 infections and 600 
healthcare associated deaths in the U.S. annually due to carbapenem-resistant organisms [2]. 
Little is known about the community-acquired prevalence of these organisms, which is likely to be 
a much smaller number as compared to the burden internationally. This may only be a result of a 
reduced prevalence of carbapenem-resistance in the United States, and/or better waste 
treatment, decreasing the introduction of carbapenem-resistant organisms into the environment.  
It is likely that the use of carbapenem antibiotics in the United States will increase over 




negative bacteria that are typically resistant to all other antimicrobial treatments with the 
exception of carbapenem antibiotics; consequently, carbapenems are considered drugs of last 
resort used to treat ESBLs [2]. Organisms with outer membrane permeability defects in 
combination with ESBL genes can also express carbapenem resistance [75]. ESBLs cause at 
least 26,000 healthcare-associated infections and1700 deaths in the U.S. each year [2]. Similar to 
carbapenem resistance, the rate of community acquisition is unknown; however, the rise in their 
prevalence in the United States gives rise to concern about the future increase in carbapenem 
resistance. One ESBL gene, the CTX-M-15 gene, was also discovered in India in the 1990s and 
has since become well-established globally [76]. In one U.S. tertiary care center, the prevalence 
of this gene in clinical samples rose from 1.7% to 26.4% between 2005 and 2012 [77]. Although 
some of this transfer likely has been clinical spread, CTX-M type ESBL genes are most 
commonly found in community-acquired pathogens and are usually associated with E. coli [76]. 
Thus it would be useful to model the potential spread of CTX-M-15 outside of the hospital setting 
to determine the optimal strategies for community based surveillance of other types of antibiotic 
resistance transmitted via the fecal-oral route, including carbapenem-resistant organisms.  
There are specific subpopulations from the U.S. and other high-income countries that 
may be at higher risk from carbapenem-resistant infections. A large number of United States 
armed forces members are currently serving in areas thought to have high burdens of 
carbapenem-resistance, specifically resistance attributable to the NDM gene [78-80]. This 
includes areas where military installations are more primitive, including Afghanistan and Pakistan. 
In these areas, soldiers may be at higher risk of becoming colonized or infected with 
carbapenem-resistant organisms [78-80]. Of particular concern is the potential that these 
organism would be spread via fecal-oral routes under unsanitary field conditions or within military 
hospitals in these countries [78, 79]. Further, upon return to the United States, admission of a 
patient colonized or infected with a carbapenemase-resistance gene increases the risk of 
nosocomial transmission to and acquisition by other patients in a U.S. healthcare facility. Cases 
of NDM colonization have previously been detected during routine surveillance within the U.S. 
military healthcare system [78]. Colonized individuals may also be a source of resistant 




resistance genes would be random culturing of stools of high-risk individuals such as members of 
the Armed Forces returning from affected areas. 
The U.S. is not invulnerable to the intrusion of carbapenem-resistant organisms into the 
drinking water supply. Some reasons this has not yet been observed are 1) surveillance has not 
been implemented, 2) a reduced prevalence of carbapenem-resistant organisms in the U.S. 
population compared to a country like India, and 3) better sanitation and drinking water 
infrastructure in the U.S. Additionally, the lack of carbapenem-resistant organisms in U.S. drinking 
water could be explained by the difference in the predominant carbapenem resistance genes in 
the U.S. versus India. In the U.S., the KPC gene predominates [81], and has a more restricted 
host range than the NDM gene, limiting its reservoir in the environment. KPCs are occasionally 
found in Pseudomonas, but are primarily restricted to E. coli and, more commonly, Klebsiella [82]. 
On the other hand, the U.S. is not immune to fecal contamination in drinking water, meaning that 
these organisms would also have the opportunity for intrusion into the drinking water distributions 
systems. If the NDM gene were to become more prevalent in the U.S., there would be an 
increased opportunity for its spread via drinking water due to the ability of the NDM gene to 
occupy a wide range of bacterial families, genera, and species [14, 83].  
Antibiotic resistance genes can find their way into a distribution system via water 
treatment plants, through horizontal gene transfer at the treatment interface [32]; consequently, 
fecal contamination of drinking water is not a prerequisite for intrusion and presence of antibiotic-
resistant organisms in U.S. drinking water distribution systems. In some locations, the distance 
between wastewater discharge and drinking water intake sources is minimal. These areas have a 
greater potential for intrusion by antibiotic resistance genes, including carbapenem resistance 
genes. Locations downstream from hospital discharge are likely to be especially vulnerable. 
Monitoring for carbapenem-resistant bacteria in the environment would ideally take place in areas 
where discharge occurs, followed by raw and drinking water sources that are downstream from 
this discharge and other substantial human activity. 
To fill the need for better testing methods to identify the presence of carbapenem-
resistant organisms in drinking water, and to further our understanding of the potential role of 




the following Specific Aims. 
Specific Aims 
To explore these critical considerations, this work has three Aims:  
1a)  Develop and validate a streamlined, low-cost method for detecting carbapenem-
resistant organisms in drinking water. 
1b)  Estimate the frequency of occurrence and species of carbapenem-resistant bacteria, 
and bacteria carrying the NDM gene, in a piped drinking water distribution system in 
an area where carbapenem-resistant infections are endemic.  
This work will address a pressing need for a screening method to identify and characterize 
carbapenem-resistant organisms in drinking water. 
2)  Assess the occurrence and rate of blaNDM-1 gene transfer from Enterobacteriaceae to 
Pseudomonas aeruginosa under planktonic (broth) conditions. 
3)  Assess the occurrence and rate of gene transfer from Enterobacteriaceae to 
Pseudomonas aeruginosa in a biofilm environment. 
This work will help to further the understanding of the potential for horizontal gene transfer of the 
blaNDM gene from several blaNDM donors to Pseudomonas aeruginosa, an opportunistic 
pathogenic organism commonly found in treated drinking water in both liquid (broth) and biofilm 
environments.  
Although one study has been done to assess the prevalence of the blaNDM gene in the 
Indian environment, including drinking water, this study may have underestimated the prevalence 
as a result of small sample volumes and long holding times. Studies looking for carbapenem-
resistant organisms in general are also lacking, despite the fact that genes for carbapenemase-
producers other than NDM are also commonly detected in Indian clinical samples [84], 
sometimes at much higher frequencies than NDM-producers [85]. A lack of simple and cost-
effective water testing methods for carbapenem-resistant bacteria creates further difficulties in 
determining the true frequency of these organisms in drinking water. 
While there are indications that transfer of antibiotic resistance genes, including the 
blaNDM gene, occurs in the environment, little has been done to examine horizontal gene transfer 




no data on the frequency in which blaNDM may transfer to specific recipient bacteria under 
environmental conditions. Understanding the potential mechanisms and frequency of blaNDM gene 
transfer in the environment, along with knowledge of its true frequency in the environment, can 
aid in a better understanding of the risk of exposure and possible areas for intervention to prevent 
transmission and community acquisition of the blaNDM and other resistance genes. 
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DEVELOPMENT AND EVALUATION OF A METHOD FOR DETECTING 
 
CARBAPENEM-RESISTANT BACTERIA IN DRINKING WATER 
Abstract 
In this current study, a fluorogenic heterotrophic plate count test for drinking water 
screening was modified and validated to detect the presence of carbapenem-resistant bacteria. 
The modified method was pilot-tested on drinking water samples (n=19) from the New Delhi, 
India distribution system followed by culture confirmation. Samples positive for fluorescence 
(n=13) were cultured, identifying nine samples containing Gram-negative bacteria. Meropenem 
minimum inhibitory concentration and species identification were determined for 21 isolates 
recovered from the nine samples. This modified screening method successfully detected eleven 
different carbapenem-resistant bacterial species from seven different sampling sites within the 
New Delhi distribution system. 
Introduction 
The rapid increase in the number of carbapenem-resistant infections, nationally and 
globally, is a significant public health concern. Infections with carbapenem-resistant bacteria often 
leave very few treatment options [1-5] resulting in high case mortality, with infections being fatal in 
approximately 50% of cases [6, 7]. Community acquisition of carbapenem-resistant bacteria, 
particularly by carbapenemase-producing organisms, is also gaining attention [4, 5, 8, 9]. Recent 
studies have discovered carbapenem-resistant bacteria in environmental samples, including 
treated drinking water [8, 10-16]. This is troubling because of the potential for large outbreaks 
and/or colonization as a result of massive dissemination of bacterial contaminants via a water 




potentially be a source of community-acquired carbapenem-resistant infections [4, 8].  
Various methods exist for detecting antibiotic-resistant bacteria in the environment 
including detecting specific resistance phenotypes using antibiotic selection on centrifuged or 
filtered water samples [8, 17, 18] or direct testing for particular resistance genes using molecular 
methods [8]. These methods can be costly, require special equipment or technical expertise, and 
may utilize small sample volumes that can distort the true frequency of the organism in the 
environment. In countries that are more likely to face significant issues with water quality and 
antibiotic resistance, these currently accepted methods for identifying carbapenem-resistant 
bacteria are typically not feasible for use in routine screening.  Standard drinking water testing 
methods utilize chromogenic or fluorogenic substrates to test for the presence of coliforms and E. 
coli in samples with volumes of at least 100 mL [19], and have previously shown promise in 
detecting antibiotic-resistant organisms when combined with selective antibiotic agents [20]. 
However, the substrates typically used in routine microbial water quality testing are only capable 
of detecting E. coli and total coliform bacteria [20, 21]. 
Walsh et al. detected NDM-1-carrying bacteria in the New Delhi environment and found 
that most of the isolates carrying the gene were not Enterobacteriaceae [8]; consequently, these 
bacteria would not be detected by the coliform enzyme-substrate tests typically used in routine 
drinking water quality testing. As a result, it is possible that carbapenem-resistant bacteria and 
carbapenem resistance genes, including carbapenemase genes, could be disseminated by tap 
water to large segments of the population via bacteria that are not the target of conventional 
drinking water treatment, nor subject to testing under current US EPA regulations or World Health 
Organization recommendations [21, 22]. Walsh et al. was also able to demonstrate horizontal 
gene transfer of the NDM-1 gene from several of these nonpathogenic environmental isolates to 
pathogens such as E. coli, Shigella, and Salmonella [8]. Therefore, even if environmental bacteria 
carrying mobile genetic resistance elements are not considered significant clinical pathogens, 





Routine screening for non-coliform bacteria in drinking water is not currently standard; 
however, these bacteria may still have the potential to transmit carbapenem resistance elements 
to pathogens. A simple screening test capable of detecting coliform and non-coliform 
carbapenem-resistant bacteria may useful in areas faced with these organisms present in the 
drinking water supply. The objective of this research was to develop, validate, and pilot a low-
cost, practical method for detecting carbapenem-resistant organisms in drinking water samples. 
Methods 
Method Development  
Four strains of Klebsiella pneumoniae and one Pseudomonas strain with varying  
susceptibilities to meropenem were used as model carbapenem-resistant or carbapenem-
susceptible organisms for method development: Klebsiella pneumoniae ATCC strain 33495, with 
a meropenem minimum inhibitory concentration (MIC) = 0.032 µg/mL; a KPC-producing 
Klebsiella pneumoniae with a meropenem MIC of 16 µg/mL; a KPC-producing Klebsiella 
pneumoniae with a meropenem MIC of >32 µg/mL; an NDM-1-producing Klebsiella pneumoniae 
(ATCC strain BAA-2146) with a meropenem MIC of >32 µg/mL, and Pseudomonas aeruginosa 
ATCC strain 27853 with a meropenem MIC of 0.25.  
IDEXX heterotrophic plate count (HPC) reagent (IDEXX Laboratories, Westbrook, Maine) 
was used in combination with various concentrations of meropenem (U.S. Pharmacopial 
Convention, Rockville, Maryland) and vancomycin (Sigma-Aldrich, St. Louis, Missouri) to 
selectively detect carbapenem-resistant Klebsiella and inhibit carbapenem-susceptible Klebsiella 
and Pseudomonas. The IDEXX reagent uses multiple proprietary fluorogenic substrates to detect 
heterotrophic bacteria in drinking water samples. Positive samples are indicated by fluorescence 
at 365 nm between 44 and 72 hours of incubation at 34-38 degrees C.  
For initial assessment of the recovery of the resistant Klebsiella strains, and to ensure the 
susceptible strain was not detected, spiked samples were tested using the HPC substrate with 
added meropenem at concentrations set at the CLSI resistant (4 µg/mL) and susceptible (1 




samples containing no antibiotic. The less resistant KPC-producer (MIC = 16) was subsequently 
tested at 0.25 µg/mL, 0.125 µg/mL, and 0.0625 µg/mL to determine the highest concentration of 
meropenem that would not inhibit recovery of this organism. To increase the specificity of the test, 
vancomycin at concentrations of 5, 6.25, 12.5, 25, and 75 µg/mL was added to the meropenem 
and these combinations were evaluated for impact on the specificity and recovery of the NDM-1-
producing strain. HPC reagent was added to the water samples first to provide a buffer in the 
sample prior to the addition of the acidic antibiotic solutions. 
Single cell detection was assessed by comparing spike recoveries of bacteria in 
deionized water containing HPC reagent alone and deionized water containing HPC reagent and 
various levels of meropenem. Overnight cultures (16-24 hours) of the KPC- and NDM-1-
producing strains were grown on tryptic soy agar (TSA) containing 0.5 µg/mL meropenem. The 
susceptible Klebsiella ATCC strain was grown overnight on TSA without antibiotics. A Dade 
Microscan turbidimeter was used to produce a bacterial suspension with an optical density of 0.1 
to 0.15, equivalent to a 0.5 McFarland standard (approximately 1.5 x 108 bacteria). The 
suspension was serially diluted in sterile phosphate buffered saline down to 1.5 x 102 organisms 
per milliliter to achieve a spiking suspension of approximately 15 organisms per 100 µL. One 
hundred microliters of each suspension was added to 100 mL of sterile deionized water 
containing the HPC reagent and the desired concentration of antibiotic. Unspiked deionized water 
controls containing reagent and the meropenem levels listed previously were also prepared. 
Samples were tested in triplicate.  
Organisms were quantified using the IDEXX Quanti-Tray® most probable number (MPN) 
method (IDEXX Laboratories, Westbrook, Maine). Quanti-Tray® was used to create estimates of 
MPNs in order to observe differences in recovery due to antibiotic inhibition. Samples were 
incubated at 35 degrees C and checked at 24, 48, and 72 hours for fluorescence using long-wave 
UV (365 nm). Results were definitive at 44 hours, but any change in recovery was also noted at 
72 hours. The average MPN counts were calculated by taking the mean of the MPN counts in 




estimated as the average MPN counts in spiked samples at each antibiotic concentration divided 
by the average MPN counts of spiked samples without antibiotic. To determine the number of 
organisms spiked into each sample, one hundred microliters of each diluted bacterial suspension 
was plated on tryptic soy agar in triplicate, and the mean spike counts were calculated for each 
organism. 
To determine if false positive fluorescence was occurring and to ensure that bacterial 
colonies could be isolated from the water samples, 20 µL of water from fluorescing wells of the 
deionized water samples was extracted and plated on CHROMagarTM KPC (DRG International, 
Springfield, New Jersey) and blood agar (Hardy Diagnostics, Salt Lake City, UT) for confirmation. 
Positive plates were confirmed based on color, colony morphology, and purity. 
MICs for each organism were determined by the broth microdilution method using the 
2012 Clinical and Laboratory Standards Institute (CLSI) Method for Dilution Antimicrobial 
Susceptibility Tests for Bacteria That Grow Aerobically [28], and the results were interpreted 
using the CLSI Performance Standards for Antimicrobial Susceptibility Testing [27].  
Method Validation  
For validation of the water screening method, unspiked tap water samples were tested in 
comparison with tap water samples spiked using the same four Klebsiella pneumoniae strains 
used in the method development. Target spikes of 15 organisms were generated for the spiked 
samples and tested at levels of 0.0625 µg/mL, 0.125 µg/mL, 1 µg/mL meropenem, and without 
meropenem. Unspiked tap water controls containing reagent and the meropenem levels listed 
above were also prepared. A final concentration of 5 µg/mL vancomycin was tested and 
evaluated with each concentration of meropenem. This level of vancomycin was found to be 
inhibitory toward nontarget tap water organisms while not affecting recovery of the target spiked 
organisms. Recoveries in spiked and unspiked tap water samples containing vancomycin were 
compared to spiked and unspiked samples without vancomycin. 
To neutralize the chlorine in the tap water samples, sterile sampling vessels containing 




and sealed using the IDEXX Quanti-Tray® sealer. To evaluate the possibility of false-positive 
detection of nonfermenting bacteria with higher CLSI carbapenem-resistance breakpoints, the 
method was also performed using carbapenem-susceptible Pseudomonas aeruginosa ATCC 
27853 (meropenem MIC = 0.25). Sterile deionized water in 120 mL sampling vessels was spiked 
with quantities of Pseudomonas comparable to spiked quantities used in testing the susceptible 
and carbapenem-resistant Klebsiella isolates. Samples were then processed using the Quanti-
Tray® method as described for the Klebsiella samples.   
The testing was also performed in both a presence-absence format using only the 
sample bottles with a target spike of 1-10 organisms. Presence absence samples were prepared 
in a similar manner by diluting the 1.5 x 108 suspension down to 1.5 x 100 and spiking into 100 
mL of sterile deionized water or tap water, and samples were incubated in the 120 mL sampling 
vessels and checked at 24, 48, and 72 hours. The spiking suspensions were also plated in 
triplicate on TSA to determine the range of spike counts. 
Application of Method to Drinking Water Samples in New Delhi, India 
Nineteen drinking water samples were collected from locations in the New Delhi area that 
were serviced by the New Delhi water distribution system. Students and faculty from the Institute 
of Virology and Immunology and the Institute of Biotechnology at Amity University in Noida, India, 
obtained water samples from their home residences. They were instructed to collect samples 
during the hours in which the water was being directly supplied from the distribution system, as 
opposed to water taken from home storage tanks. They were also instructed to flush plumbing 
fixtures for two minutes prior to sampling and to discard of any samples that were accidentally 
contaminated by the sampler. 
Each sample collector collected two 100 mL samples from their home tap into bottles 
containing sodium thiosulfate to neutralize any chlorine residual. Sample collectors tested each 
tap for free and total chlorine residual using test strips (HACH, Loveland, Colorado). The chlorine 
test strips were able to detect a minimum of 0.5 ppm chlorine.  




Immunology in Noida, India. Samples were typically processed between 4 and 24 hours of 
collection and were kept refrigerated in transit where possible. IDEXX heterotrophic plate count 
reagent was first added to each sample followed by an aliquot of vancomycin and meropenem 
suspensions to achieve a final concentration of 5 µg/mL vancomycin and 0.125 µg/mL of 
meropenem per sample. Conservative concentrations were selected based on the results of the 
method validation discussed below and to facilitate the detection of carbapenemase-producing 
organisms with modest MICs. The reagent was tested in sterile water samples to ensure no false 
positive fluorescence and antibiotic solutions were plated on blood agar to test for purity.   
Sample bottles with reagent and antibiotics were mixed and incubated at 37 degrees C. 
The bottles were checked for fluorescence at 24 and 48 hours. After 48 hours of incubation, but 
prior to 72 hours of incubation, 20 µL of liquid from each positive (fluorescent) sample bottle was 
plated onto blood agar, MacConkey agar containing 0.5 µg/mL meropenem, and CHROMagarTM 
KPC, streaked to isolation and incubated overnight at 37 degrees C. Blood agar was used to 
isolate growth for colony differentiation purposes and to suggest when positive fluorescence was 
due to non-carbapenem-resistant bacterial growth in positive samples that did not show growth 
on the MacConkey or CHROMagarTM plates. The KPC plates were used to indicate Gram 
negative bacterial growth and whether isolates were E. coli or other Enterobacteriaceae. 
MacConkey agar was similarly used to indicate whether bacterial isolates were fermenting or 
nonfermenting Gram negative bacteria. The CHROMagarTM and MacConkey plates were not 
otherwise used for further isolate processing. 
If growth was observed on the CHROMagarTM KPC or the MacConkey Agar plates, all 
isolates from the corresponding blood agar were streaked to isolation on additional blood agar, 
CHROMagarTM KPC,  MacConkey agar with 0.5 µg/mL meropenem, and Mueller Hinton agar with 
0.5 µg/mL meropenem and incubated overnight at 37 degrees C.  
Bacterial identification was performed using the NF Plus RapID kit (Remel, Lenexa, KS) 
or the RapID One kit (Remel, Lenexa, KS) as determined by the oxidase test results. Minimum 




Etest strips (bioMérieux Clinical Diagnostics, Marcy l'Etoile, France). Each organism was also 
tested by antibiotic disk diffusion to determine the zones of inhibition for 10 antibiotics: 
Cefotaxime, Ceftazidime, Imipenem, Meropenem, Aztreonam, Gentamicin, Tobramycin, 
Ciprofloxacin, Tigecycline, and Colistin. 
Isolates that could not be tested at the time of sample processing were streaked to pure 
culture and frozen in glycerol at -80 degrees C until testing could be completed. 
Results 
Method Development and Validation 
Recovery of Klebsiella in Sterile Deionized Water with Meropenem 
Average MPN recoveries for each organism in spiked deionized water at various 
meropenem concentrations are listed in Table 2.1. The average MPN counts of the spikes in 
deionized water without antibiotic were lower than the average spike counts on tryptic soy agar 
plates after 24 hours incubation. No fluorescence was observed in any of the unspiked samples 
at any of the antibiotic concentrations. Organisms were detected in each of the spiked samples 
without antibiotic with MPNs ranging from 14 to 26 per 100ml. The carbapenem-susceptible 
ATCC Klebsiella was not recovered at any of the meropenem levels tested. Meropenem 
concentrations reflecting the CLSI breakpoints were initially used (1 µg/mL and 4 µg/mL), but the 
less resistant KPC-producing Klebsiella (MIC = 16) could not be recovered at either of these 
concentrations. This strain was subsequently tested at meropenem concentrations of 0.25 µg/mL 
and 0.125 µg/mL. The use of 0.125 µg/mL meropenem resulted in MPN counts of the less 
resistant Klebsiella strain at 48 hours similar to the MPN counts of these spikes without antibiotic 
(12.4 vs. 13.9 per 100ml). At a meropenem concentration of 1 µg/mL, the NDM-producing 
Klebsiella and the more resistant KPC-producing Klebsiella (MIC>32) were both recovered at 
MPNs similar to the spiked controls with no antibiotic.  At 4 µg/mL, however, the NDM-producer 
(MIC>32) was not recovered, and the more resistant KPC-producer (MIC>32) was recovered at 
somewhat lower levels than the spiked sample without antibiotic (16.1 vs. 20.5 per 100 mL).  











































(MIC = 0.25) 
       
Average TSA plate 
counts  no antibiotic 
NAa 26.7 21.3 30 27 17 
       
MPN Counts 
No meropenem NGb 14.0 13.9 20.5 26.4 21.9 
       
0.125 µg/mL meropenem NTc NT 12.4 (93%) NT NT NG 
       
0.25 µg/mL meropenem NT NT NT NT NT NG 
       
1 µg/mL meropenem NG NG NG 20.9 (102%) 30.7 (116%) NT 
       
4 µg/mL meropenem NG NG NG 16.1 (78%) NG NT 
       
 
a NA = Not Applicable  
b NG = No Growth 




wells from the Klebsiella spiked samples was extracted and plated on blood agar and 
carbapenem-supplemented KPC agar. Of all 460 positive fluorescent wells, 458 grew isolates on 
both agars, with the exception of the wells spiked with carbapenem-susceptible Klebsiella; these 
grew only on the blood agar.  
Recovery of Pseudomonas in Sterile Deionized Water with Meropenem  
To determine whether carbapenem-susceptible Pseudomonas--which has higher CLSI 
carbapenem resistance breakpoints than Enterobacteriaceae--would be detected at low 
concentrations of meropenem, sterile deionized water samples spiked with Pseudomonas 
aeruginosa ATCC strain 27853 were tested at meropenem concentrations of 0.125 µg/mL or 0.25 
µg/mL (Table 2.1). Pseudomonas was recovered from the spiked samples that did not contain 
meropenem, but detection was inhibited at meropenem concentrations of 0.125 µg/mL and 0.25 
µg/mL. 
Recovery in Tap Water with Meropenem and Vancomycin  
Average MPN counts of spiked organisms in tap water with various combinations of 
meropenem and vancomycin antibiotic are listed in Table 2.2. In tap water containing no 
antibiotic, all spiked and unspiked samples grew organisms, indicating the presence of nontarget 
organisms. The tap water containing no antibiotics spiked with carbapenem-susceptible Klebsiella 
had a much higher average organism count than other organism spikes without antibiotic (MPN > 
2000). This was most likely the result of large numbers of organisms being flushed from the tap 
during water sampling. Tap water was collected separately for each organism, mixed, and divided 
into 100 mL aliquots. Counts on tryptic soy agar indicated that approximately 14 organisms on 
average were spiked into each sample for the carbapenem-susceptible Klebsiella. This suggests 
that meropenem successfully removed the majority of the more than 2000 nontarget tap water 
organisms and the carbapenem-susceptible Klebsiella at a concentration of 0.0625 µg/mL. In the 
unspiked control samples, 0.0625 µg/mL meropenem reduced the MPN counts by approximately 








































(MIC = 0.25) 
       
Average TSA plate counts  no 
antibiotic 
NAa 13.7 14.3 25.3 25.7 11.3 
       
MPN Counts 
No antibiotic 18.6 >2190.7 17.8 27.8 24.1 40.6 
       
0.0625 µg/mL meropenem  1.7 0.7 14.7 NTc NT 11.3 
       
0.0625 µg/mL meropenem +  
5 µg/mL vancomycin 
NGb NG 12.2 NT NT 5.5 
       
0.125 µg/mL meropenem 1.7 NT 10.2 NT NT 11.2 
       




NT 13.4 NT NT 3.4 
       
1 µg/mL meropenem 2.4 NT NG 21.7 23.4 NT 
       
1 µg/mL meropenem + 5 µg/mL 
vancomycin 
NG NT NG 25.4 23.6 NT 
       
 
a NA = Not Applicable 
b NG = No Growth 




Meropenem levels of 0.0625 and 0.125 µg/mL did not appear to impact the concentration of 
susceptible Pseudomonas in tap water, while the addition of vancomycin reduced the 
concentration by only half. 
The addition of 5 µg/mL vancomycin to this meropenem concentration optimized the test 
by successfully inhibiting growth of the remaining tap water organisms without compromising the 
recovery of the target carbapenem-resistant organisms. Concentrations higher than 5 µg/mL 
vancomycin were tested but were inhibitory toward the growth of the target carbapenemase-
producing organisms, particularly at higher levels of vancomycin. When combined with 1 µg/mL 
meropenem, concentrations of 25 µg/mL reduced NDM-1 recovery by 56%, and when combined 
with 75 µg/mL reduced NDM-1 recovery by 94%.   
Based on the inhibition of the carbapenem-susceptible Pseudomonas and Klebsiella 
observed in the deionized water spikes, it was assumed that 1 µg/mL meropenem would inhibit 
the growth of carbapenem-susceptible Pseudomonas and Klebsiella, and as a result, the tap 
water spikes were not prepared at this meropenem concentration.  
At a meropenem concentration of 1 µg/mL, the more resistant KPC-producer (MIC>32) 
and the NDM-producer (MIC>32) exhibited MPN counts similar to the average spike counts on 
tryptic soy agar. The addition of 5 µg/mL vancomycin did not reduce the MPN. No growth was 
observed in tap water spiked with the less resistant KPC-producer (MIC = 16) at 1 µg/mL 
meropenem, with or without vancomycin. 
Effect of Incubation Time 
To determine the effect of incubation time on the sensitivity and specificity of the test, 
changes in MPN between 24 and 48 and 48 and 72 hours were assessed. MPN counts for spiked 
deionized water samples at 24, 48, and 72 hours are listed in Table 2.3. No increase was 
observed in MPN count in the majority of the Klebsiella-spiked deionized water samples from 24 
hours to 72 hours. The few samples that did exhibit an MPN increase were typically spiked 
samples with no antibiotic. The maximum MPN increase in the Klebsiella spikes was 1.6 after 48 













































aeruginosa     
(MIC = 0.25) 
       
No Meropenem 
MPN 
24 hours 14 13.9 20.5 26 14.7 
48 hours 14 13.9 20.5 26.4 21.9 
72 hours 14 15.5 20.5 26.4 21.9 
       
0.125 µg/mL meropenem 
MPN 
24 hours NTa 12.4 NT NT NG 
48 hours NT 12.8 NT NT NG 
72 hours NT 12.8 NT NT NG 
       
0.25 µg/mL meropenem 
MPN 
24 hours NT NT NT NT NG 
48 hours NT NT NT NT NG 
72 hours NT NT NT NT NG 
       
1 µg/mL meropenem 
MPN 
24 hours NGb NG 20.9 30.7 NT 
48 hours NG NG 20.9 30.7 NT 
72 hours NG NG 20.9 30.7 NT 
       
4 µg/mL meropenem 
MPN 
24 hours NG NG 14.8 NG NT 
48 hours NG NG 16.1 NG NT 
72 hours NG NG 16.1 NG NT 
       
a NT = Not Tested 




spiked samples containing no antibiotic, but no further change was observed between 48 and 72 
hours. Tap water samples with no antibiotic or containing only meropenem exhibited significant 
changes in MPN count between 48 and 72 hours (Table 2.4). No significant change was 
observed in MPN count in tap water samples containing vancomycin selection. 
Application to 100 mL Presence/Absence Test 
To determine whether this method could be adapted to a simple presence/absence 
format with sufficient sensitivity, triplicate bottles were spiked  with low levels of organisms and 
examined for fluorescence after 24, 48, and 72 hours. TSA counts indicated that between one 
and four organisms were spiked into each sample. The bottles indicated good presence/absence 
detection even at low organism levels, with the exception of the less resistant KPC-producer (MIC 
= 16), which did not exhibit growth in bottles containing antibiotic. Presence/absence results for 
each triplicate sample set at different antibiotic concentrations are listed in Table 2.5.  
In the 100 mL bottles, the 0.125 µg/mL antibiotic level was sufficient for suppressing 
growth of the carbapenem-susceptible Klebsiella while allowing detection of the carbapenem-
resistant KPC- (MIC>32) and NDM-producers (MIC>32). As demonstrated in the quantitative tap 
water tests, 5 µg/mL vancomycin successfully inhibited any growth from nontarget organisms in 
bottles of tap water. Fluorescence in all positive spiked sample bottles was observed by 24 hours 
of incubation. The only increase in detection at 48 hours versus 24 hours was in the unspiked tap 
water samples that did not contain antibiotic. 
Samples from New Delhi, India 
After validation of the method using simulated tap water samples containing 
carbapenem-resistant bacteria, field validation of the method was performed using 19 samples 
from the New Delhi water distribution system. Of the 19 New Delhi municipal water system taps 
sampled, 68% (n=13) of the samples gave a positive fluorescent result with the fluorogenic 
heterotrophic plate count reagent in the presence of 0.125 µg/mL meropenem and 5 µg/mL 









Table 2.4. Effect of Incubation Time on MPN Count at 24, 48, and 72 Hours in Spiked Tap Water Samples 
Meropenem concentration Incubation time 
 
No organism 




























(MIC = 0.25) 
        
No antibiotic 
MPN 
24 hours NG 8.6 15.1 24.6 22.7 0.7 
48 hours 18.6 >2190.7 17.8 27.7 24.1 40.6 




24 hours NG NGa 14.3 NT NT 0.7 
48 hours 1.7 0.7 14.7 NT NT 11.3 
72 hours 31 10.5 26.8 NT NT 32.7 
0.625 µg/Ml 
Meropenem 
+ 5 µg/Ml Vancomycin 
MPN 
24 hours NG NG 11.4 NT NT 0.3 
48 hours NG NG 12.2 NT NT 5.5 
72 hours NG NG 12.2 NT NT 5.5 
0.125 µg/mL Meropenem 
MPN 
24 hours NG NTa 10.2 NT NT 0.7 
48 hours 1.7 NT 10.2 NT NT 11.2 
72 hours 14.8 NT 15.6 NT NT 37.5 
0.125 µg/mL Meropenem 
+ 5 µg/mL Vancomycin 
MPN 
24 hours NG NT 13.0 NT NT 0.3 
48 hours NG NT 13.4 NT NT 3.4 
72 hours NG NT 13.4 NT NT 3.4 
1 µg/Ml Meropenem 
MPN 
24 hours NG NTb NG 21.7 23.4 NT 
48 hours 2.4 NT NG 21.7 23.4 NT 
72 hours 50.6 NT 30.9 24.5 24.9 NT 
1 µg/mL Meropenem 
+ 5 µg/mL Vancomycin 
MPN 
24 hours NG NT NG 25.4 23.6 NT 
48 hours NG NT NG 25.4 23.6 NT 
72 hours NG NT NG 26.5 23.6 NT 
        
a NT = Not Tested 

















































      
 Deionized water 
No antibiotics 0 1 2 3 2 
      
0.125 µg/mL meropenem + 5 µg/mL vancomycin 0 
 
0 0 2 2 
1 µg/mL meropenem + 5 µg/mL vancomycin 0 0 0 2 2 
      
 Tap water 
No antibiotics 3 3 3 3 3 




0 3 2 
1 µg/mL meropenem + 5 µg/mL vancomycin 0 0 0 3 3 





MacConkey agar containing 0.5 µg/mL meropenem. Residual chlorine was not detected at any of 
the sampling sites. A total of 29 organisms were isolated, 27 of which were Gram-negative, and 
multiple organisms were recovered from eight of the ten samples that exhibited growth on 
MacConkey agar. One of the samples grew only a Gram-positive organism. Ultimately Gram-
negative bacteria were isolated from nine of the 19 samples. Thirteen isolates could not be 
recovered from frozen culture to perform antibiotic disk zone of inhibition testing. Six of these 13 
isolates did not have speciation or MIC testing completed. A total of 21 Gram-negative isolates 
were identified and had MICs determined. Sterile water HPC samples were negative for 
fluorescence, and cultures of the antibiotic solutions did not exhibit any growth on blood agar. 
Table 2.6 lists the 21 isolated Gram-negative organisms and their minimum inhibitory 
concentrations. The CLSI resistant breakpoint for each organism is listed in parentheses next to 
the organism name. Shaded rows indicate the eight organisms that were considered resistant to 
meropenem by 2014 CLSI criteria [29]: Acinetobacter spp., Pseudomonas oryzihabitans, 
Alcaligenes faecalis, Pseudomonas aeruginosa, Shigella spp, Pseudomonas spp., E. coli, 
Burkholderia cepacia. Minimum inhibitory concentrations ranged from 0.38 ug/mL to >32 ug/mL 
(the upper limit of the meropenem Etest strip). Multiple Pseudomonas, Burkholderia, Alcaligenes, 
and Acinetobacter species were recovered. Stenotrophomonas maltophilia, which exhibits 
intrinsic resistance to meropenem, was recovered from three of the samples. Carbapenem-
resistant E. coli and Shigella were also recovered. Many of the organisms exhibited resistance to 
antibiotics other than carbapenems. Table 2.7 lists the Ceftazidime, Imipenem, Meropenem, 
Aztreonam, Gentamicin, Tobramycin, Ciprofloxacin, Tigecycline, and Colistin antibiotic disk zones 
of inhibition for 16 of the isolates. The E. coli isolate was resistant to all of the antibiotics tested, 
with the exception of gentamicin and tobramycin. Zone diameter interpretive criteria were not 
available for “other non-Enterobacteriaceae” or for colistin and tigecycline antibiotics [29]. The 
Shigella isolate exhibited resistance to every antibiotic tested. Using the CLSI zone diameter 
interpretive criteria, the E. coli isolate was resistant to the carbapenems, ceftazidime, 




Table 2.6. Identification and Meropenem Minimum Inhibitory Concentrations 






   
23-1 Alcaligenes faecalis (≥16) 1 
23-3 Stenotrophomonas maltophilia (Intrinsic) >32 
104-1 Pseudomonas spp. (≥16) 1.5 
105-1 Burkholderia cepacia (≥16) 0.38 
105-2 Acinetobacter spp. (8) 24 
107-1 Pseudomonas oryzihabitans (≥16) >32 
107-3 Alcaligenes faecalis (≥16) >32 
125-2 Pseudomonas aeruginosa (8) 1 
125-3 Stenotrophomonas maltophilia (Intrinsic) >32 
125-4 Pseudomonas aeruginosa (8) 3 
125-5 Pseudomonas spp. (≥16) 2 
141-2 Pseudomonas spp. (≥16) 8 
143-1 Pseudomonas aeruginosa (8) 24 
143-2 Stenotrophomonas maltophilia (Intrinsic) >32 
143-3 Burkholderia cepacia (≥16) 2 
143-4 Acinetobacter spp. (8) 0.38 
143-5 Shigella spp. (4) >32 
145-2 Pseudomonas spp. (≥16) 24 
147-1 Escherichia coli (4) >32 
147-2 Burkholderia cepacia (≥16) 16 
147-3 Pseudomonas spp. (≥16) 4 






































            
23-1 A. faecalis 0 0 0 27 0 30 25 25 0 0 
23-3 S. maltophilia 0 0 0 28 18 0 0 0 31 13 
107-1 P. oryzihabitans 0 12 21 35 20 0 0 0 33 0 
107-3 A. faecalis 27 28 30 35 9 26 22 21 21 26 
125-2 P. aeruginosa 15 17 25 30 15 27 32 24 20 30 
125-3 S. maltophilia 0 20 26 29 17 31 0 0 35 30 
125-4 P. aeruginosa 27 19 29 31 14 21 13 16 10 25 
125-5 Pseudomonas spp. 15 16 25 31 16 26 32 23 18 31 
141-2 Pseudomonas spp. 0 17 26 35 18 31 0 0 35 29 
141-3 B. cepacia 0 0 NTa 31 20 20 0 0 36 23 
143-1 P. aeruginosa 26 15 24 34 14 14 11 15 15 23 
143-2 S. maltophila 0 11 33 34 20 32 0 0 34 30 
143-4 Acinetobacter spp. 0 17 23 37 10 36 38 42 34 37 
143-5 Shigella spp. 0 0 0 0 0 0 0 0 0 0 
147-1 E. coli 14 0 0 0 10 18 10 0 12 18 
147-3 Pseudomonas spp. 20 19 30 31 16 25 34 0 19 28 
            




Pseudomonas aeruginosa isolates recovered, two had intermediate or full resistance to imipenem 
by the disk method, but only one of these had a corresponding resistant MIC by the Etest 
method. 
Discussion 
The development of cost-effective and feasible analytical methods for identifying 
antibiotic-resistant bacteria or antibiotic resistance genes in the environment has been lacking 
[30]. Most accepted methods are time-consuming, expensive, or are difficult to perform in low 
resource settings [31].  
Enzyme substrate methods are commonly used in drinking water testing, and have 
previously been applied to detection of antibiotic-resistant E. coli in sewage [20], but have not 
been specifically applied to detection of carbapenem-resistant bacteria in drinking water or 
organisms other than Enterobacteriaceae. We have adapted a fluorogenic HPC method to detect 
carbapenem-resistant Enterobacteriaceae and non-Enterobacteriaceae bacteria in drinking water 
and have successfully recovered multiple species of carbapenem-resistant bacteria from drinking 
water. This method combines the ability to selectively detect carbapenem-resistant heterotrophic 
bacteria with the simplicity of established enzyme substrate methods and facilitates the analysis 
of standard volumes of water used in routine drinking water testing [31]. This method can be 
performed in the laboratory using the Quanti-Tray® or presence-absence procedures and can 
also be applied in the field using the presence-absence protocol.  
This method has demonstrated good sensitivity and specificity, though nontarget 
organisms may still be detected due to differences in carbapenem resistance classification based 
on bacterial genus. Other limitations of this method include the inability to directly identify specific 
resistance genes and the length of incubation time required to detect nonfermenting carbapenem-
resistant organisms. Though resistance genes are not directly identified, the purpose of this 
modification was to create a method that could screen for possible carbapenem-resistant 
organisms, and isolates may be tested for the presence of specific carbapenem resistance 




resistance for their genus and species. For many of the organism species we isolated, there is no 
specific data available on what MIC would be considered clinically resistant. 
Antibiotic concentrations were set conservatively to enable recovery of carbapenemase-
producing organisms that might exhibit lower MICs. As a result of higher CLSI carbapenem 
resistance breakpoints for non-Enterobacteriaceae, the method may have reduced specificity 
when detecting these organisms [27]. Enterobacteriaceae have the lowest carbapenem MIC 
breakpoints for carbapenem-resistance; consequently, non-Enterobacteriaceae that are not 
carbapenem-resistant may still be detected at lower meropenem concentrations set to detect 
intermediate or less resistant Enterobacteriaceae. Pseudomonas—a bacterial contaminant 
commonly found in drinking water, has a higher CLSI carbapenem resistance breakpoint than 
Enterobacteriaceae [27], and could potentially cause false positive results. In our modified 
method, detection of Pseudomonas was successfully inhibited by low levels of meropenem in 
sterile deionized water, but Pseudomonas spiked tap water containing meropenem and 
vancomycin did exhibit positive fluorescence. In the field samples taken from the New Delhi 
distribution system, multiple non-Enterobacteriaceae were detected with MICs below their 
corresponding clinical resistance breakpoints. However, it is possible that during sample 
processing and testing, unstable plasmids carrying carbapenemase genes were lost, as 
previously described in isolates recovered from New Delhi drinking water [8]. 
We also discovered that setting antibiotic concentrations at the CLSI MIC breakpoints 
proved to be too high for detection of individual carbapenem-resistant organisms, unless they had 
extremely high MICs. An inoculum effect was evident for the NDM-producer and the less resistant 
KPC-producer (data not shown). While the CLSI MIC indicates that an organism is inhibited by a 
specific concentration of antibiotic, the CLSI MIC testing method is typically done with 5 x 105 
organisms [28]. Our water test method is designed to detect individual carbapenem-resistant 
organisms, so antibiotic concentrations are set at far more conservative levels than the 
corresponding MIC. As a result, organisms with MICs as low as 0.38 were recovered from New 




the test were sufficient to inhibit nontarget organisms in U.S. tap water, but may need to be raised 
when testing water in developing countries to ensure a greater specificity. However, this may also 
result in decreased sensitivity in detecting organisms with lower MICs that may still carry 
carbapenem resistance genes. 
We also observed that the use of meropenem alone in spiked tap water samples was 
insufficient in inhibiting excess bacterial growth of nontarget tap water organisms, which was not 
observed in the spiked sterile deionized water samples. Increased specificity was achieved by 
supplementing with vancomycin, which suppressed the growth of nontarget bacteria in the tap 
water that were not inhibited by meropenem. The detection of 50% more Pseudomonas after 48 
hours of incubation and the increased detection of nontarget tap water organisms after 24 hours 
indicate that nonfermenting organisms may take longer to detect. Limiting the incubation period to 
48 hours or less for tap water samples may increase the specificity of the test, but could also 
potentially decrease the sensitivity of the test for slow growing carbapenem-resistant organisms.  
Because this is a phenotypic test for carbapenem-resistant organisms, this method does 
not detect carbapenemase-producing bacteria specifically, but may also detect bacteria that have 
developed resistance to carbapenems through porin loss, efflux upregulation, and other 
resistance mechanisms [32-34]. However, if detection of specific resistance genes is desired, the 
resistant bacteria can be isolated from fluorescent wells or sampling vessels and further 
analyzed. This method also gives an option for isolate recovery, which may be useful for 
epidemiological purposes, including comparisons with clinical samples. 
Appropriate laboratory testing techniques may produce a more accurate assessment of 
the current prevalence of carbapenem-resistant organisms in drinking water. Molecular methods 
are promising techniques for detecting antibiotic resistance genes in the environment; however, 
they still require significant sample preparation, are expensive, detect nonviable organisms, and 
only detect specific resistance genes rather than certain classes of antibiotic-resistance [35]. 
Furthermore, countries facing the most severe impacts of ARG dissemination in aquatic 




Future research should attempt to compare the capability of this method to other 
currently accepted methods in the detection of antibiotic-resistant heterotrophs in drinking water. 
To further increase the sensitivity and/or specificity of the method, antibiotic concentrations could 
be fine-tuned using drinking water known to have carbapenem-resistant bacteria present. 
Ultimately, this method may help to provide vital information to public health officials and water 
supply engineers about the prevalence of carbapenem-resistant bacteria in drinking water 
distribution systems and the potential for colonization and transmission of carbapenem-resistant 
organisms in piped community water systems by common, nonpathogenic, heterotrophic bacteria 
that are currently unregulated and thought to be of little public health significance. 
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INFLUENCE OF NUTRIENT CONCENTRATION ON TRANSFER 
 
OF THE BLANDM GENE INTO PSEUDOMONAS AERUGINOSA 
Background 
Antibiotic resistance is a serious public health threat that is no longer a future concern. A 
recent report from the CDC conservatively estimates that each year at least 23,000 deaths in the 
United States are attributable to antibiotic resistance [1], with an annual cost of US $21 to $34 
billion dollars to the U.S. healthcare system. Globally the problem of antibiotic resistance is 
thought to be even more catastrophic. A 2014 World Health Organization report on antimicrobial 
resistance cites two of the six WHO regions as reporting at least 50% carbapenem resistance in 
hospital- or community-acquired Klebsiella isolates, with all six regions reporting resistance to 
third generation cephalosporin resistance in at least 50% of isolates [2]. In the South-East Asia 
region, as much as 54% of Klebsiella isolates have been reported as carbapenem-resistant [2]. 
The increase in these multidrug-resistant organisms is frightening, especially those resistant to 
carbapenem antibiotics as such infections leave few, if any, treatment options, and the spread of 
these resistant organisms is emerging and increasing at an alarming rate [2, 3].  
Gram-negative bacteria can develop carbapenem resistance through multiple 
mechanisms such as outer membrane protein mutations, efflux upregulation, and 
carbapenemase production [4-6].  Carbapenemase-producing bacteria can transfer the genes 
encoding for these carbapenem-hydrolyzing enzymes. In 2008, a new carbapenem resistance 
gene, designated New Delhi metallo-β-lactamase-1, or NDM-1 (blaNDM-1), was discovered in 
strains of bacteria believed to have originated from India [7]. The NDM gene codes for a 
carbapenemase that is classified as a metallo-beta-lactamase (MBL). Plasmids carrying blaNDM 




[8]. These plasmids also readily demonstrate interstrain, interspecies, and intergenus transfer, 
and as a result, global transmission of NDM has been significantly attributed to the transfer of the 
gene in addition to clonal proliferation of bacterial strains harboring the gene [8]. 
Since its discovery, bacterial strains carrying the NDM gene have been reported in more 
than 40 countries including the United States [8], with a crude morality rate of 23.8% for NDM 
infections versus 10.3% for those presumed to be colonized but not infected [3]. The blaNDM has 
been implicated in numerous hospital outbreaks and community-acquired infections around the 
world [3, 8], and has even been detected from bacteria in environmental samples, including tap 
water samples [9].  
The blaNDM gene is frequently found in Enterobacteriaceae [6, 10], but has also been 
detected in nonfermenting opportunistic Gram-negative strains, such as Pseudomonas and 
Acinetobacter [6, 11]. Pseudomonas is ubiquitous in the environment [12], and is commonly 
found in water distribution systems [12, 13]. Furthermore, transfer of the blaNDM gene from 
Pseudomonas species to E. coli has previously been demonstrated [9], as has the transfer of 
other MBL genes from Pseudomonas to Enterobacteriaceae [5]. Thus it could potentially serve as 
an intermediate reservoir for the NDM gene and play a major role in disseminating the blaNDM 
gene to pathogenic organisms.  
Pseudomonas aeruginosa is of particular concern as it is frequently associated with 
nosocomial infections [14], including infections associated with hospital water distribution system 
(ref). However, the only experimental effort to transfer the blaNDM gene into Pseudomonas 
aeruginosa in a laboratory setting was not successful [15]. Several factors can influence the 
frequency of gene transfer in conjugation experiments, including pH, growth phase, temperature, 
and nutrient concentration [9, 16, 17]. Because Pseudomonas is often found in low nutrient 
environments (e.g., tap water distribution systems), the occurrence and frequency of gene 
transfer may be affected by a high nutrient environment, as was used in the previous 
experimental work [15].   The purpose of this study was to determine whether blaNDM gene 




in a low nutrient environment.  
Methods 
Part 1: Broth Conjugations into E. coli J53  
Conjugations into an azide-resistant E. coli J53 strain were attempted using four different 
blaNDM-positive Enterobacteriaceae strains. Two of the donor strains were kindly provided by 
Mark Toleman (Cardiff Institute of Infection and Immunity): an environmental Klebsiella isolate 
and an environmental E. coli ST101 isolate; one Klebsiella donor strain was provided by the 
Colorado Department of Health Public Health Lab; and one Klebsiella donor strain was acquired 
from the American Type Culture Collection (ATCC) (strain BAA-2146). The azide-resistant J53 
recipient strain was also provided by Dr. Toleman.  
Cultures of the E. coli J53 recipient and NDM donor bacteria were grown to log phase at 
37 degrees C with constant agitation in Luria Bertani (LB) broth. After incubation, optical densities 
of the NDM donor and the J53 recipient were taken to establish accurate donor to recipient ratios. 
Cells were rinsed by centrifuging them at 8000 rfc for 10 minutes, the broth supernatant was 
extracted, and cells were resuspended in 1 mL fresh LB.  
The sequence of experimental procedures are presented in Figure 3.1. Conjugation 
experiments were conducted at 30 and 37 degrees C. Proportions of each rinsed cell suspension 
corresponding to 1 x 108 cells for the NDM donor bacteria and 1 x 107 of the J53 E. coli recipient 
cells were combined in a 1.5 mL microcentrifuge tube and additional LB was added to achieve a 
final volume of 1 mL. Each NDM donor and J53 recipient combination was incubated overnight at 
30 and 37 degrees C and then serially diluted to 10-5 in LB. The 10-1, 10-3, and 10-5 dilutions were 
immediately plated on LB agar containing 0.5 µg/mL meropenem and 100 µg/mL sodium azide. 
Conjugation suspensions were also plated on CHROMagarTM and TSA without selection to 
confirm culture purity. 
Transfer of the NDM plasmid from the Klebsiella strains into the J53 E. coli strain was 
confirmed on CHROMagarTM KPC (DRG International, Springfield, New Jersey). Transfer from 










of E. coli K-12, from which J53 is derived [18, 19]. The presence of the NDM gene in 
transconjugant colonies from all three donor strains was confirmed by PCR using the primer set 
described by Poirel et al. [20]. 
Part 2: Broth Conjugations into Rifampin-Resistant Pseudomonas 
NDM conjugations into a strain of rifampin-resistant Pseudomonas (Toleman lab, Cardiff 
University) were attempted using three J53-NDM transconjugants as donors. Optical densities of 
log phase cultures were obtained as described above, with an intended donor to recipient ratio of 
1:4. To assess whether nutrient concentration affected conjugation rates, cells were resuspended 
in 10%, 50%, or 100% LB broth following centrifugation of the log phase cultures. Donor and 
recipient cells from the 10% suspensions were combined and 10% LB added to bring the total 
volume to 1 mL. The 50% and 100% LB suspensions were similarly combined and diluted. The 
conjugation mixtures were incubated overnight at 30 degrees C, which has previously been 
shown to result in higher NDM transfer frequency than other temperatures [9, 15]. 
Following incubation, the suspensions were serially diluted and the 10-1, 10-2, and 10-3 
dilutions were plated on tryptic soy agar (TSA) containing three different combinations of rifampin 
and ticarcillin: 100 µg/mL ticarcillin and 50 µg/mL rifampin, 100 µg/mL ticarcillin and 200 µg/mL 
rifampin, or 75 µg/mL ticarcillin and 100 µg/mL rifampin. Ten microliters of the donor and recipient 
cultures, as well as the undiluted conjugation mixtures were plated on CHROMagarTM and TSA 
without selection to assess culture purity. Plates were incubated for 48 hours, with examination 
for growth at 24 hours. 
Colonies from the rifampin-ticarcillin TSA plates were streaked to isolation on 
CHROMagarTM KPC supplemented with 0.5 µg/mL meropenem. Sample lysates were prepared 
by boiling Pseudomonas colony growth on the CHROMagarTM plates and tested for the NDM 





Minimum Inhibitory Concentrations 
Minimum inhibitory concentrations of the donor strains, the E. coli J53 strain, the E. coli 
J53 transconjugants, and the rifampin-resistant Pseudomonas strain were determined using a 
meropenem Etest (bioMérieux Clinical Diagnostics, Marcy l'Etoile, France). 
Results 
Part 1: Broth Conjugations into Azide-Resistant E. coli 
NDM transfer into J53 E. coli was observed for three of the four donor isolates: the 
environmental Klebsiella, the ATCC NDM BAA-2146 Klebsiella strain, and the environmental E. 
coli ST101 strain. Transfer rates are listed in Table 3.1. The rate of transfer was highest with the 
environmental Klebsiella strain, followed by the ATCC strain, and was least frequent in the E. coli 
ST101 strain. No NDM transfer was observed using the Colorado outbreak Klebsiella strain as a 
donor. Transfer frequencies were 40 to 50% higher at 30 degrees versus 37 degrees with the 
exception of the ST101 strain, which was the same at both temperatures. 
Part 2: Broth Conjugations into Rifampin-Resistant Pseudomonas 
There was no evidence of transfer of the NDM gene from any of the three J53 NDM 
transconjugant strains under any of the conditions tested. Mutant ticarcillin-resistant colonies 
were observed for all three strains at the three nutrient concentrations used, and counts 
increased with higher nutrient levels increased.  Colonies subcultured to CHROMagarTM were 
negative for NDM in PCR analyses. No colony growth was observed on TSA plates containing 
100 µg/mL ticarcillin and 200 µg/mL rifampin and E. coli growth dominated the plates containing 
100 µg/mL ticarcillin and 50 µg/mL rifampin. 
Minimum Inhibitory Concentrations 
Minimum inhibitory concentrations for all strains used are listed in Table 3.2. All four 
donor strains had meropenem MICs >32 µg/mL.  The azide-resistant J53 E. coli strain 
meropenem MIC was very low (0.125 µg/mL) prior to conjugation.  The J53 E. coli 




Table 3.1. Conjugation Frequencies of NDM-Carrying Donor Strains into Azide-Resistant J53 E.  
coli at 30 Degrees and 37 Degrees C Expressed as Number of Transconjugants per Recipient  
Donor organism 10:1 D/R 30 C 10:1 D/R 37 C 
   
ATCC strain BAA 2146 Klebsiella pneumoniae 4.0 x 10-4 2.6 x 10-4 
Environmental Klebsiella – Bangladesh 5.5 x 10-3 4.0 x 10-3 
Environmental E. coli ST101 strain 3.5 x 10-5 3.5 x 10-5 
Colorado NDM Hospital Outbreak Strain < 1 x 10-8 < 1 x 10-8 
   





Table 3.2. Minimum Inhibitory Concentrations of Donor, Recipient, 








ATCC BAA-2146 Klebsiella NDM  >32 
Environmental Klebsiella NDM  >32 
Environmental E. coli ST101 NDM  >32 
Colorado Outbreak Klebsiella NDM 25124  >32 
  
Recipient  
Azide-resistant J53 E. coli  0.125 
Rifampin-resistant Pseudomonas 1.0 
  
Transconjugant  
J53 E. coli  (ATCC BAA-2146 Klebsiella)   >32 
J53 E. coli (Environmental Klebsiella) 24 







However, the environmental Klebsiella and E. coli ST101 transconjugants had lower MICs than 
their parent donors. 
Discussion 
The blaNDM gene is a resistance factor that has the ability to spread to many different 
bacterial species, including Pseudomonas. Pseudomonas aeruginosa isolates carrying the NDM 
gene have been identified in clinical samples as well as from the environment [9, 11]. Previous 
conjugation studies have demonstrated the transfer of the NDM gene from Pseudomonas species 
to enteric bacteria [9]. Horizontal gene transfer from a common enteric pathogen such as E. coli 
to Pseudomonas aeruginosa would be significant as it would indicate that Pseudomonas could 
act as both a reservoir of the blaNDM gene and as the causative pathogen for carbapenem-
resistant infections in hospital and community settings. Pseudomonads are commonly found in 
water distribution systems [21, 22] and nosocomial outbreaks of Pseudomonas have been traced 
to hospital water, including piped water systems where the organism could potentially spread to 
large numbers of residents or patients [23-25]. 
The transfer of the blaNDM from Klebsiella and E. coli strains to a J53 E. coli was 
confirmed as reported in other studies [9, 15]. Conjugation rates were lower at higher 
temperatures, as has been observed by other investigators [9, 15]. Conjugation from the 
Colorado Outbreak NDM strain to the J53 E. coli was not observed. It is unknown whether the 
Colorado Outbreak NDM strain carries NDM on a plasmid or on the chromosome, but other 
possibilities such as carriage on a nonmobilizable plasmid, or low transfer frequency may also 
have been factors. 
Using the same methodology, NDM gene transfer from the J53 E. coli to Pseudomonas 
aeruginosa was not observed at any of the nutrient levels used in this experiment. This result is 
consistent with the only other published NDM conjugation study using Pseudomonas aeruginosa 
as a recipient [15]. Various factors can influence conjugation occurrence and frequency, including 
growth phase, temperature, pH, and nutrient availability [9, 15-17]. Given that transconjugants 




counts were seen with higher nutrient concentrations, allowing for more colonies to be screened; 
however, transfer frequencies may be independent of colony count.  
Another possible reason that conjugation was not observed in this experiment or in the 
work conducted by Potron et al. [15] is that transfer of the blaNDM gene from E. coli to 
Pseudomonas may occur at an extremely low frequency. It is also possible that conjugation did 
occur, but the plasmids were unstable in the Pseudomonas recipient and were lost upon 
subculturing onto CHROMagarTM. Walsh et al. noted that the majority of the environmental 
Pseudomonas isolates recovered had unstable NDM plasmids [9].  
Plasmid host range is also a significant factor for transferring plasmids into new host 
organisms. The compatibility group of the Environmental Klebsiella donor strain in unknown, but 
the ATCC strain has been documented as an A/C compatibility group [26]. Likewise, the E. coli 
ST101 strain is an A/C plasmid (Mark Toleman, personal communication). A/C plasmids are 
considered broad host range plasmids, and can be acquired by and replicate within 
Pseudomonas [10]. However, none of the donor or recipient bacterial strains were profiled for 
other plasmid carriage. It is possible that the rifampin-resistant Pseudomonas may harbor other 
plasmids that are incompatible with the donor plasmids carrying the NDM gene.  
The negative results in this study indicate that the hypothesized action did not occur 
under these specific sets of experimental conditions. Given the public health significance of NDM 
gene transfer into Pseudomonas aeruginosa, further investigation is warranted into the conditions 
under which NDM transfer can occur. While Pseudomonas carrying the blaNDM gene is often 
found in clinical and environmental samples [9, 11], it is possible that this organism acquires the 
gene through mechanisms other than conjugation. Future work could also attempt to determine 
whether the NDM gene can be transferred by other types of horizontal gene transfer. Bacterial 
acquisition of the NDM gene is a serious medical and public health threat. Increased 
understanding of the influences and mechanisms of NDM gene transfer may inform interventions 
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TRANSFER OF THE BLANDM GENE TO PSEUDOMONAS 
 
AERUGINOSA UNDER BIOFILM CONDITIONS 
Abstract 
Global spread of the blaNDM gene is an emergent public health crisis. The presence of this 
gene in environmental bacteria as well as in clinical isolates indicates the severity of the 
dissemination and the potential for community acquisition of bacteria harboring the blaNDM gene. 
Horizontal gene transfer is known to play a significant role in the spread of the blaNDM gene. 
Opportunistic organisms such as Pseudomonas aeruginosa may be able to acquire the blaNDM 
gene and subsequently transfer it to other organisms. Transfer of the blaNDM gene into 
Pseudomonas has not been demonstrated under traditional broth conjugation conditions, but may 
be facilitated by biofilm formation. Horizontal gene transfer of the blaNDM gene within biofilms has 
enormous implications for environmental and clinical spread of this resistance factor. We 
demonstrate the transfer of the blaNDM gene from a clinical Klebsiella donor isolate into an E. coli 
intermediate and subsequently into Pseudomonas aeruginosa recipient within a biofilm. 
Background 
The global increase in antibiotic-resistant infections is a serious public health concern. In 
the U.S. alone, 23,000 deaths are attributed to antibiotic resistance each year [1], with an annual 
cost of US $21 to $34 billion dollars [2]. The rising number of hospital-acquired and community-
acquired carbapenem infections is especially concerning, as carbapenem-resistant infections 
leave few, if any, treatment options [3]. Carbapenem resistance is spreading rapidly on a global 
scale.  A 2014 World Health Organization (WHO) report on antimicrobial resistance states that 




community-acquired Klebsiella isolates [2].  
Carbapenem resistance can be mediated through multiple mechanisms, including efflux 
upregulation, outer membrane protein mutation, and carbapenemase production [4-6]. Of these 
mechanisms, carbapenemase production is particularly concerning because the genes that code 
for these carbapenemases can be transferred to other bacteria, spreading resistance horizontally 
as well as vertically [7].  
In 2009, a new carbapenem resistance gene, designated NDM-1(blaNDM), was discovered 
in a patient repatriated to Sweden from India [8]. Since its discovery, NDM has spread to over 40 
countries on 6 continents [7]. The global spread of the blaNDM gene is attributed to horizontal 
spread more than dissemination of clonal organisms [7]. The blaNDM gene has been observed in 
many species and genera of Gram-negative bacteria and has also demonstrated a high degree of 
interspecies and interlineage transferability [7, 9].  
The blaNDM gene has been detected in both clinical and environmental samples, including 
tap water [10-14]. Although many of the bacterial species harboring the blaNDM gene that have 
been recovered from environmental samples are considered nonpathogenic and opportunistic 
organisms, there is evidence that they can transfer the blaNDM gene to E. coli and other 
Enterobacteriaceae on mobile genetic elements [10, 14, 15]. Consequently, carriage of the blaNDM 
gene by nonfermenting, nonpathogenic waterborne bacteria is still a significant concern because 
they can 1) serve as a reservoir of the blaNDM gene that could later be transferred to pathogenic 
bacteria and 2) be transmitted to large segments of the population via bacteria that are neither 
the target of conventional drinking water treatment, nor subject to water testing under current 
regulations [16, 17]. Widespread dissemination of antibiotic resistance genes via drinking water 
has enormous implications for public health and nosocomial infection prevention. Thus it is 
important to understand the mechanism(s) whereby species such as PA acquire the NDM gene 
so that effective prevention measures can be developed.  
Biofilm environments have been shown to facilitate horizontal gene transfer of resistance 




biofilms than between bacteria in a planktonic state [18-20]. Hospital outbreaks attributed to 
antibiotic-resistant bacteria have been traced to biofilms in sinks, including outbreaks due to 
bacteria harboring the blaNDM gene [21-23]. Thus biofilms, such as those commonly found in 
water distribution systems, may serve as not only a reservoir of antibiotic resistance genes such 
as blaNDM, but also as a source of amplification for resistance genes.  
Walsh et al. detected the blaNDM gene in multiple species of environmental bacteria that 
commonly compose distribution system biofilms, including Pseudomonas [10]. However, blaNDM 
transfer to Pseudomonas could not be demonstrated in laboratory experiments [10, 24]. 
Pseudomonas species are frequently found in both piped drinking water and the biofilm lining the 
pipes of water distribution systems [25-28] and have been shown to be associated with the 
formation of biofilms [27, 29]. Biofilm growth conditions may facilitate the transfer of antibiotic-
resistance genes [20], including blaNDM, to Pseudomonas. The objective of this study was to 
determine if the blaNDM gene can be transferred from Enterobacteriaceae donors to 
Pseudomonas in a controlled biofilm environment. 
Methods 
Broth Conjugations into Azide-Resistant E. coli J53 
NDM conjugations into the standard J53 azide-resistant E. coli strain were attempted 
using four different strains of Enterobacteriaceae carrying the blaNDM gene as donors. Two of the 
donor strains, an environmental Klebsiella and an environmental E. coli, were kindly provided by 
Dr. Mark Toleman (Cardiff Institute of Infection and Immunity). Another donor Klebsiella strain 
was provided by the Colorado Department of Public Health Laboratory (CO-25124). Finally, one 
donor Klebsiella strain was obtained from the American Type Culture Collection (ATCC) isolate 
BAA-2146. An azide-resistant J53 E. coli recipient strain was also provided by Dr. Toleman. 
Cultures of the blaNDM donor bacteria were grown to log phase in Luria Bertani (LB) at 37 
degrees C in a shaker. To foster culture purity, frozen stocks of the blaNDM donors contained 0.5 
µg/mL meropenem and the J53 stocks contained 50 µg/mL sodium azide. After incubation, 




recipient ratios. To ensure that residual meropenem and azide were not present in the 
conjugations, cells were spun down at 8000 rpm for 10 minutes, the broth supernatant was 
extracted, and cells were resuspended in 1 mL fresh LB. The donor and recipient cultures were 
combined in a 10:1 donor to recipient ratio as used by Walsh et al. [10]. Subsequently, 
proportions of each cell suspension corresponding to 108 NDM donor cells were combined with 
107 J53 recipient cells and diluted to 1 mL in LB broth. Conjugation mixtures were incubated 
overnight at 30 and 37 degrees C. After incubation, the conjugation mixture was serially diluted to 
10-1, 10-3, and 10-5 dilutions in LB and these dilutions were immediately plated on LB agar 
containing 0.5 µg/mL meropenem and 100 µg/mL sodium azide. 
Putative J53 transconjugants from the Klebsiella donors were confirmed as E. coli on 
CHROMagarTM (DRG International, Springfield, New Jersey) containing 0.5 µg/mL meropenem. 
Transfer from the environmental E. coli strain into J53 was confirmed by PCR using primers 
specific to the yja-A gene found in J53 [30, 31]. Presence of the blaNDM gene was detected by 
running PCR products on a 2% agarose gel using the primer set described by Poirel et al. [32].  
Biofilm Conjugations into Rifampin-Resistant Pseudomonas 
A rifampin-resistant Pseudomonas was used as a recipient for the blaNDM biofilm 
conjugation experiments. The rifampin-resistant Pseudomonas was also kindly provided by Dr. 
Mark Toleman. Transconjugant donors from the J53 broth conjugations described above and the 
rifampin-resistant Pseudomonas recipient were grown in pure culture to log phase. Optical 
densities of log phase cultures were obtained as described above. To prevent excessive E. coli 
overgrowth, a donor to recipient ratio of 1:4 was used, combining 1 x 108 Pseudomonas recipient 
cells with 2.5 x 107 cells from each of the respective J53 transconjugant donor cultures and 
diluted up to 1 mL with LB.  
For each donor strain, biofilms were grown in 48-well plastic trays for two time periods 
(24 hours and 72 hours) in three nutrient concentrations (10%, 50%, and 100% LB), resulting in 
six different conditions for each blaNDM donor.  The biofilms were cultivated after 24 and 72 hours 




hours from each biofilm well, discarded, and 1 mL fresh LB was added to each well at the same 
concentration as originally used.  
For donor strains demonstrating transfer to Pseudomonas under the above conditions, 
further conjugation experiments were performed to determine if the blaNDM gene could transfer 
within a layered biofilm, where a Pseudomonas biofilm was initially generated and followed by 
introduction of the NDM donor strain. This was accomplished by placing 108 Pseudomonas 
recipient cells in 1 mL LB (100%) in the 48-well trays, incubating for 24 hours to allow initiation of 
biofilm formation. After a 24-hour Pseudomonas biofilm was formed, the LB broth was removed, 
and the wells were rinsed with a fresh mL of LB. Following rinsing, 1 mL LB containing 
approximately 108 cells of the J53-NDM transconjugant strain previously demonstrating conjugal 
transfer into Pseudomonas under mixed conditions were added to wells containing the 24-hour 
Pseudomonas biofilms and then incubated for another 48 hours, with LB exchange occurring 24 
hours after addition of the J53 blaNDM donor culture. 
Biofilms were cultivated by extracting the broth from the well, rinsing with 1 mL fresh LB, 
removing that broth, and adding another 1 mL of LB broth. The biofilm was then scraped from the 
sides of the well using a sterile metal scraper/scoop. The 1 mL LB containing the biofilm 
scrapings was removed and placed in a microcentrifuge tube and pulse-vortexed to break apart 
the cells. The contents of the tubes were then serially diluted in LB to 10-2 and 100 µL of each 
dilution was plated in duplicate on tryptic soy agar (TSA) containing three different combinations 
of rifampin and ticarcillin: 100 µg/mL ticarcillin and 50 µg/mL rifampin, 100 µg/mL ticarcillin and 
200 µg/mL rifampin, or 75 µg/mL ticarcillin and 100 µg/mL rifampin. Plates were incubated at 37 
degrees C for 48 hours and checked for growth at 24 hours. 
Ten microliters of the donor and recipient cultures, as well as the undiluted conjugation 
mixtures were plated on CHROMagarTM and TSA without selection to assess culture purity. 
Plates were incubated for 48 hours, with examination for growth at 24 hours. Colonies were 
subcultured to CHROMagarTM containing 0.5 µg/mL meropenem. Sample lysates were prepared 




the NDM primer set referred to above.  
Transfer of blaNDM into Pseudomonas was confirmed by sequencing the PCR products 
from blaNDM positive lysates. Resulting sequences were compared to the Genbank database to 
confirm amplification of the 621 base pair blaNDM gene segment. The absence of the J53 E. coli 
donors in the sample lysates was confirmed using the yja-A primer set described above. As an 
added assurance, the absence of Klebsiella NDM donor contaminants was verified using a 
Klebsiella primer set [33]. Pseudomonas aeruginosa presence was confirmed using a primer set 
described by Spilker et al. [34].  
Minimum Inhibitory Concentrations 
Minimum inhibitory concentrations of the donor strains, the E. coli J53 strain, the E. coli 
J53 blaNDM transconjugants, the rifampin-resistant Pseudomonas strain, and the Pseudomonas 
blaNDM transconjugants were determined by meropenem Etest (bioMérieux Clinical Diagnostics, 
Marcy l'Etoile, France). Growth around the highest concentration on the Etest strip was tested for 
the presence of the blaNDM gene by PCR. 
Results 
Conjugations into Azide-Resistant E. coli J53 
NDM transfer was seen with three of the four donor Enterobacteriaceae isolates: the 
environmental Klebsiella, the ATCC BA2146 Klebsiella strain, and the environmental E. coli 
strain. No transfer was observed using the CO-25124 strain. Transfer rates are listed in Table 
4.1. As observed in other studies, transfer rates were somewhat lower at higher temperatures (37 
vs. 30 C) for the ATCC and environmental Klebsiella donors; there was no apparent effect of 
temperature on transfer rates for the other two donors. 
Biofilm Conjugations into Rifampin-Resistant Pseudomonas 
Transfer frequencies using J53 transconjugants of each strain as donors are listed in 
Table 4.2. No blaNDM gene transfer to Pseudomonas was observed under any of the conditions 




Table 4.1. Conjugation Frequencies of NDM-Carrying Enterobacteriaceae Strains 
into Azide-Resistant J53 E. coli at 30 Degrees and 37 Degrees Celsius 
Expressed as Number of Transconjugant per Donor Cell  
Organisms 30 degrees C 37 degrees C  
   
ATCC strain BAA 2146 Klebsiella pneumonia 4.0 x 10-5 2.6 x 10-5 
Environmental Klebsiella – Bangladesh 5.5 x 10-4 4.0 x 10-4 
Environmental E. coli strain 3.5 x 10-6 3.5 x 10-6 
CO-25124 < 1 x 10-8 < 1 x 10-8 

















Table 4.2. Conjugation Frequencies of J53-NDM Transconjugants into Rifampin- 
Resistant Pseudomonas at 30 Degrees Celsius by Broth Nutrient 
Concentration and Biofilm Growth Time Expressed as Number 
of Pseudomonas NDM Transconjugants per Donor Cell 
J53 transconjugant strain 10% LB 50% LB 100% LB 
    
 24 h BF 72 h BF 24 h BF 72 h BF 24 h BF 72 h BF 
ATCC strain BAA 2146 K. pneumonia  < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 1.3 x 10-6 
Environmental Klebsiella < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 
Environmental E. coli < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 < 4 x 10-8 
       
Note. LB = Luria Bertani broth. BF = Biofilm. 
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Transfer of the blaNDM gene from the ATCC J53 transconjugant donor was observed after 72 
hours of biofilm formation in 100% LB. Transfer frequency under these conditions was very low at 
1.3 x 10-6 transconjugants per donor or 3.3 x 10-7 per recipient. Transfer of the blaNDM gene from 
the ATCC J53 transconjugant donor to Pseudomonas in a layered biofilm was also observed at a 
rate of 7 x 10-7 transconjugants per donor and per recipient.  
The transconjugants were positive for the blaNDM gene by PCR (see Figure 4.1) and 
sequencing of the positive bands confirmed blaNDM. PCR for the presence of residual E. coli 
donor cells in the Pseudomonas NDM transconjugant lysates was negative (see Figure 4.2). PCR 
amplification was positive for Pseudomonas (Figure 4.3). Putative NDM transconjugant colonies 
did not grow on the TSA containing 100 µg/mL ticarcillin and 200 µg/mL rifampin, even at the 
lowest dilutions. Growth was observed on the TSA plates containing 100 µg/mL ticarcillin and 50 
µg/mL rifampin as well as on the TSA plates containing 75 µg/mL ticarcillin and 100 µg/mL 
rifampin; however, plates containing only 50 µg/mL rifampin were overgrown with E. coli at the 
10-1 and 10-2 dilutions. 
Minimum Inhibitory Concentrations 
The minimum inhibitory concentrations for each donor, transconjugant, and recipient 
isolate used are listed in Table 4.3. The MICs of the Pseudomonas NDM transconjugants were all 
>32 as compared to a MIC of 12 for a control Pseudomonas isolate that was taken through the 
same biofilm cultivation and antibiotic selection steps. An image of the MIC testing for one of the 
Pseudomonas NDM transconjugants is presented in Figure 4.4.  
Discussion 
To our knowledge, conjugal transfer of the blaNDM gene into Pseudomonas has not 
previously been demonstrated in a laboratory setting. We have demonstrated transfer of the 
blaNDM gene from the ATCC BAA-2146 donor strain into Pseudomonas aeruginosa via a J53 
transconjugant intermediate. Gene transfer occurred under conditions that suggest that biofilm 




Figure 4.1. Inverted gel of Pseudomonas isolates testing positive for the blaNDM 
















Table 4.3. Minimum Inhibitory Concentrations of Donor, Recipient, 
and Transconjugant Strains as Determined by Etest 
Strain 





ATCC BAA-2146 Klebsiella NDM  >32 
Environmental Klebsiella NDM  >32 
Environmental E. coli ST101 NDM  >32 
Colorado Outbreak Klebsiella NDM 25124  >32 
  
Recipient  
Azide-resistant J53 E. coli  0.125 
Rifampin-resistant Pseudomonas preconjugation 1.0 
Rifampin-resistant Pseudomonas post biofilm and 




J53 E. coli  (ATCC BAA-2146 Klebsiella)   >32 
J53 E. coli (Environmental Klebsiella) 24 
J53 E. coli (Environmental E. coli ST101)  32 








Figure 4.4. Meropenem minimum inhibitory concentration Etest 




consecutive biofilm formation of the Pseudomonas recipient and ATCC J53 blaNDM donor culture. 
We did not observe blaNDM gene transfer in broth cultures when using the same donor and 
recipient strains used in biofilm experimental conditions (data not shown). This is consistent with 
the only other study that has reported attempts to transfer blaNDM into Pseudomonas via 
conjugation [24]. It is possible that the duration of the experiment also influenced transfer 
frequencies, as we did not observe transfer in the 24-hour biofilms. We did not conduct 
comparable broth conjugations for 72 hours; however, 6 to 18 hours is typically accepted as 
sufficient time for conjugation to occur when continuous mixing of donor and recipient organisms 
occurs [35, 36]. We cannot exclude the possibility that conjugation actually occurred in the mixed 
planktonic culture initially placed in the biofilm trays, followed by adherence of the blaNDM-
Pseudomonas transconjugants to the sides of the trays; however, we were able to demonstrate 
transfer of blaNDM to Pseudomonas in a consecutive layered biofilm. The stage of biofilm growth 
may also influence transfer rates. Quorum sensing regulation and genetic exchange is thought to 
occur in the third stage of biofilm formation, when biofilms have reached a thickness of 10uM or 
greater and biofilm architecture begins to form [29, 37]. This would explain the higher transfer 
frequency in the 72-hour biofilms, though neither the stages nor thickness of biofilm growth were 
characterized in this study. 
We were able to replicate these results in subsequent experiments; however, 
approximately one in every two experiments did not yield any Pseudomonas blaNDM 
transconjugants, this may be attributed to the low frequency of transfer observed for the 
Pseudomonas recipient. Multiple blaNDM Pseudomonas transconjugants were recovered during 
the initial testing; however, this might be the result of the inheritance of the blaNDM gene in 
Pseudomonas daughter cells [20], suggesting an even lower transfer rate than was observed. 
Accurately quantifying transconjugants from biofilm is also be problematic due to difficulties in 
harvesting all of the biofilm from the walls of the biofilm trays. 
Nutrient concentrations may have some influence on transfer rates; however, transfer 




truly impacted by nutrient concentration, or if the lack of detection was due to decreased transfer 
frequency. Lower nutrient conditions yielded fewer putative transconjugant colonies, and, as a 
result, fewer colonies were screened for the blaNDM gene from the lower nutrient conditions. 
Conjugational transfer may have also occurred initially, but the presence of plasmids 
incompatible with the NDM-carrying plasmid may have subsequently resulted in loss of the NDM 
plasmid upon subculturing the possible transconjugants. Plasmid host range may also have been 
a factor in the lack of observed blaNDM transfer from the environmental E. coli and Klebsiella 
donors. The environmental E. coli was an A/C-type broad host range plasmid (Mark Toleman, 
personal communication), as was the ATCC BAA-2146 donor [38]; however, no transfer from the 
environmental E. coli was observed, which may also be associated with the lower J53 
conjugation frequency observed with this strain. The plasmid incompatibility group for the 
environmental Klebsiella was not known.  We cannot exclude the possibility that the 
environmental Klebsiella and E. coli strains carry the blaNDM gene on plasmids that lack the ability 
to self-transfer. Successful conjugation of the blaNDM gene from these strains into the J53 E. coli 
may have been facilitated by a helper plasmid in the original strains.  
Transfer of the blaNDM gene into Pseudomonas has serious public health implications, 
especially because of the widespread presence Pseudomonas species in the environment. This 
is particularly concerning for water distribution systems, including hospital water systems, where 
Pseudomonas is often associated with waterborne disease outbreaks, and where biofilm 
formation is common [25, 27, 37, 39-41]. When Walsh et al. sampled drinking water in New Delhi 
for NDM-carrying organisms, one site yielded recovery of three organisms of different species all 
carrying the NDM gene, including a Pseudomonas aeruginosa strain. This suggests the 
possibility that these organisms may have been part of a biofilm and that horizontal gene transfer 
may have occurred within the biofilm [10]. The implication that biofilms may facilitate transfer of 
the blaNDM gene to Pseudomonas suggests that environments conducive to biofilm formation, 
such as piped distribution systems, may serve as a source of blaNDM dissemination and 




nature, our conditions provide a useful experimental model of natural environmental biofilm 
formation and permit us to study bacterial conjugation events resulting in transfer of blaNDM. 
Research indicates that the frequency of such conjugation is higher in natural multispecies 
biofilms than in our model as a result of more potential recipients and a more stabilized biofilm 
structure [20, 29], suggesting that blaNDM transfer in environmental biofilms may constitute a 
significant mode of NDM spread, and perhaps other resistance plasmids as well.  
Future work on blaNDM horizontal gene transfer should focus on the establishing authentic 
multispecies biofilms and creating conditions that more closely imitate biofilm formation in nature, 
as well as documenting the transfer rates under these conditions. There is also an opportunity for 
investigation into alternative mechanisms of horizontal gene transfer of the blaNDM gene within 
biofilms and other environmental compartments.   
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Antibiotic resistance is a medical and public health emergency once thought to be a 
concern only in healthcare settings. However, community-acquired antibiotic resistance is 
becoming a global problem that requires immediate attention. Carbapenem resistance is 
particularly alarming because of the lack of options available to treat these infections. 
Carbapenem resistance dissemination in the community could be--and in some locations, 
currently is--a crisis that needs to be addressed without delay. In some locations, one 
hypothesized source of community-acquired carbapenem resistance is through drinking water. 
Drinking water distribution provide a means whereby carbapenem resistance factors can be 
disseminated to a large proportion of the population by organisms commonly found in treated 
drinking water not typically thought to be of concern, and for which no regulatory monitoring is 
currently in place. 
Routine water quality monitoring typically focuses on specific organisms or classes of 
organisms and does not take into account any phenotypic resistance to antibiotics or to the 
carriage of antibiotic resistance genes. But some organisms that are phenotypically resistant to 
antibiotics, including carbapenem antibiotics, still have the potential to cause opportunistic 
antibiotic-resistant infections, and even more concerning, if these organisms carry their resistance 
factors on mobile genetic elements, they can horizontally transfer their resistance genes to other 
organisms, including pathogens, both in the environment as well as in the human gastrointestinal 
tract. 
To better understand the public health implications of carbapenem resistance in the 
environment and subsequent community acquisition, a clear idea of prevalence and potential for 




detect carbapenem-resistant organisms in drinking water, used this method to identify resistant 
organisms in drinking water from the New Delhi, India distribution system, and assessed the 
potential for transfer of one of the major community-acquired carbapenem resistance genes, 
blaNDM, to Pseudomonas aeruginosa, an opportunistic and ubiquitous waterborne organism in 
drinking water distribution systems.   
Modification of a fluorogenic heterotrophic plate count test with carbapenem antibiotics 
yielded a useful method to screen for carbapenem-resistant organisms in drinking water samples. 
Development of the test involved selecting an antibiotic concentration that was sensitive enough 
to detect known carbapenem-resistant strains at documented MIC levels, while still being specific 
enough to suppress growth of nontarget organisms. This was somewhat difficult because of the 
different minimum inhibitory concentration breakpoints that characterize different organism 
genera and species as clinically resistant. Enterobacteriaceae have lower MIC breakpoints as 
compared to other common environmental bacteria, such as Pseudomonas. Because of the 
potentially pathogenic nature of Enterobacteriaceae and its role as an indicator in routine water 
quality testing, antibiotic concentrations were set low with the intention of detecting these 
organisms over any potential suppression of nontarget organisms such as Pseudomonas and 
Acinetobacter.  
A combination of meropenem and vancomycin were sufficient for eliminating any growth 
from general heterotrophic bacteria in unspiked tap water samples used in validation testing. An 
evaluation of the selected concentrations (noted below) in spiked deionized water, compared to 
spiked samples containing no antibiotic, indicated that the final selected concentrations did not 
adversely impact detection of the target organisms. A final concentration of 0.125 µg meropenem 
per 100 mL sample was found to be ideal in suppressing nontarget growth, while allowing for 
recovery of target organisms. The addition of vancomycin was useful for suppressing nontarget 
bacterial growth from Gram-positive organisms, which could still be detected by a general 
heterotrophic plate count reagent and are not always suppressed by meropenem. Although 




vancomycin were found to be inhibitory toward recovery of target Gram-negative carbapenem-
resistant organisms. Recoveries of target organisms at various concentrations of vancomycin 
alone were assessed compared to suppression of indigenous bacterial growth from tap water to 
ultimately select a concentration of 5 µg vancomycin per 100 mL sample as a suitable choice for 
increasing specific detection of carbapenem-resistant Gram-negative organisms.  
The development and validation of the method were successful when tested on tap water 
from the United States. The method was sensitive enough to detect the target spiked 
carbapenemase-producing organisms in sterile deionized and in tap water. The method was 
specific enough to suppress the organisms inherent in the tap water, though detection of a spiked 
Pseudomonas was occasionally possible using this combination of antibiotic concentrations. 
The method appears to be a useful tool for screening treated drinking water for 
carbapenem-resistant organisms. Though the method may allow for detection of some nontarget 
organisms, such as Pseudomonas, the antibiotic modifications were designed to lean toward 
sensitivity at the cost of some specificity. This will help produce an effective environmental 
screening method for pathogens that can detect carbapenem-resistant bacteria. These bacteria 
pose a serious threat to public health in any situation, but are especially troubling in the context of 
a drinking water distribution system, where large-scale dissemination of these pathogens is 
possible.  
In a global context, particularly in developing countries, dissemination of carbapenem-
resistant organisms and carbapenem resistance genes via drinking water is an even more critical 
public health issue. Inadequate sanitation and hygiene practices, as well as the use of untreated 
or inadequately treated water for drinking, leads to transmission of fecal-oral diseases, and 
billions worldwide lack access to adequate sanitation and millions do not use improved sources of 
drinking water [1]. Significant proportions of people in some areas have been shown to shed 
carbapenem-resistant bacteria in their stools [2-4]. Thus there is an alarming potential for 
widespread dissemination of such organisms. An easy, reliable screening method could have a 




drinking water treatment for pathogens, but also antibiotic resistance genes or resistance 
phenotypes, such as carbapenem resistance.  
The method developed for detection of carbapenem-resistant organisms was taken to 
New Delhi, India, to assess whether the test could be successful in detecting target organisms 
where prevalence of these resistant bacteria is considered endemic, and to verify the presence 
and frequency of these resistant organisms. The method successfully recovered multiple bacterial 
isolates with clinical resistance to carbapenem antibiotics, including both bacteria that are not the 
focus of typical water quality monitoring, as well as bacteria that are considered pathogenic and 
are the primary focus of water quality testing, globally.  
Although there were few samples, over 50% of them grew Gram-negative organisms, 
eleven of which were carbapenem-resistant by clinical treatment standards, and five of which 
putatively carry the blaNDM gene. These five organisms were from five separate samples sites, 
which ultimately corresponds to a blaNDM detection rate of over 25% of the sample sites tested. 
This may suggest that the carbapenem resistance dissemination problem in New Delhi tap water 
is far worse than the 4% of samples first indicated by Walsh et al. [5]. However, this may at least 
partially be attributed to testing volume, given that we tested between three to five times as much 
volume as Dr. Walsh and colleagues. Other factors that might contribute to different results 
include sample transport time, an actual increase in the environmental frequency of carbapenem-
resistant organisms and blaNDM carriers, or a combination of all of these factors. Irrespective of 
the differences between our results and the results of Walsh et al. [5], our data indicate that the 
presence of carbapenem-resistant bacteria in New Delhi tap water is a pervasive problem with a 
significant potential for causing community-acquired infections. Our method of detection provides 
a better way to screen for carbapenem-resistant Gram-negative organisms so that information on 
the prevalence in drinking water can be more easily collected and monitored in real time, 
potentially allowing for intervention in real time.     
One reason it is critical to know the prevalence of these resistant organisms in the 




resistance genes between species and genera within environmental niches as well as within the 
human gastrointestinal tract. A seemingly nonpathogenic organism may carry a resistance gene 
and be considered nonthreatening because it is unlikely to cause clinical infection; however, 
research has demonstrated the transfer of many of these resistance genes from nonpathogenic 
organisms to pathogens and human commensal bacteria in both laboratory settings as well is in 
human clinical cases. In fact, the presence of resistance genes, including carbapenemase-
encoding genes, in nonpathogenic, heterotrophic bacteria is in some ways more of a threat 
because they can go undetected in water that is routinely tested for microbiological quality given 
that most water quality monitoring tests for specific organisms rather than genotypic and 
phenotypic antibiotic resistance.  
Previous research has clearly demonstrated that many antibiotic resistance genes can 
move between species and genera in both aqueous and biofilm environmental conditions. 
Because transfer of the blaNDM carbapenemase gene from nonpathogens to E. coli has been 
repeatedly demonstrated in laboratory setting, there is no reason to not believe that blaNDM has 
the potential to also spread via horizontal gene transfer under environmental conditions. Transfer 
of the blaNDM gene in environmental biofilms particularly raises the public health threat because it 
could increase the carriage in bacteria that are not routinely monitored and which may frequently 
make it past traditional water treatment. Introduction of the blaNDM gene into a water distribution 
system biofilm may subsequently allow the system to 1) become a reservoir for the gene, and 2) 
create conditions where the distribution system becomes a source of amplification and 
dissemination of the gene. 
Although other studies have demonstrated the transfer of the blaNDM gene from 
nonfermenting organisms, such as Pseudomonas species, into E. coli, researchers have not 
been able to demonstrate the ability of Pseudomonas to accept the blaNDM gene from other 
bacteria carrying the gene. However, Pseudomonas aeruginosa and other Pseudomonas species 
carrying the blaNDM gene are commonly found in environmental and clinical samples, including in 




Pseudomonas species are commonly found in the environment, particularly in water sources, 
including drinking water. They also have the propensity to form biofilms, including in these 
environmental conditions. When Walsh et al. recovered a Pseudomonas aeruginosa isolate 
carrying the blaNDM gene from New Delhi tap water, it was accompanied by two other species of 
bacteria, suggesting that genetic exchange had occurred in the sample source [5]. Because 
environmental biofilms are known to be an excellent environment for exchange of genetic 
information, it could be inferred that the transfer of the blaNDM gene to Pseudomonas occurred 
within the biofilm. 
We sought to create experimental conditions in the laboratory that would facilitate 
transfer of the blaNDM gene from Enterobacteriaceae donors to Pseudomonas aeruginosa. No 
blaNDM transfer to Pseudomonas was observed in the standard planktonic broth cultures typically 
used in conjugation experiments, nor was transfer observed in biofilms that had only been 
forming for 24 hours. We did, however, observe blaNDM transfer in samples where mixed cultures 
were able to form biofilm growth over 72 hours, and in layered biofilm cultures where biofilms of 
the Pseudomonas recipient and ATCC blaNDM J53 donor were formed consecutively. This 
indicates that biofilms may be a major mechanism that contributes to the spread of the blaNDM 
gene, especially in the environment. As previously discussed, the transfer of this gene to other 
environmental bacteria only increases the opportunity for the gene to disseminate in the 
environment, which ultimately increases the opportunity for the gene to be acquired human 
beings. The human gastrointestinal tract can be thought of as one large biofilm with which 
nonpathogenic and pathogenic organisms can interact and exchange genetic material. 
Our experiments suggest that biofilms may facilitate the transfer of the blaNDM gene to 
certain bacteria, including Pseudomonas aeruginosa. However, our experimental conditions do 
not reflect completely authentic environmental or human biofilm conditions. Demonstration of 
blaNDM transfer was variable, with transfer only being observed in approximately half of the 
experiments performed, indicating a very low, and sometimes unobservable, rate of transfer. 




other environmental bacteria, in experiments that mirror actual environmental conditions. This 
work could look at transfer rates as well as at which species of bacteria are capable of acquiring 
the gene. This could be used to estimate the extent of this exchange on the scale of entire 
drinking water distribution systems. These data could be coupled with more data on 
environmental frequency of blaNDM and other carbapenem-resistant organisms in drinking water to 
inform interventions or to assess the risk of blaNDM gene acquisition from drinking water. 
Community-acquired antibiotic resistance is a critical public health concern, particularly 
for resistance to carbapenems, which are considered some of our last resort drugs. More 
exploration into the role of water treatment and sanitation in the spread and dissemination of 
carbapenemase-encoding genes is vital to our understanding of community acquisition of these 
genes. Epidemiological studies using the blaNDM gene as a model resistance gene could be 
conducted to examine the roles of environmental factors, such as sanitation measures, water 
distribution system characteristics, associated water quality factors, and demographic features on 
the transfer of the gene through the population. 
As the prevalence of carbapenem-resistant infections continues to grow in currently 
impacted area and areas where few, if any, cases have been seen, there may be a need for 
increased surveillance to identify high-risk individuals who may be carrying the NDM gene into 
the country. One option for monitoring the introduction of NDM genes would be random culturing 
of stools of high-risk individuals such as members of the Armed Forces returning from affected 
areas. 
The presence of such genes may also be tracked through monitoring of wastewater from 
hospital facilities treating infected patients. Wastewater from communities may also be monitored 
where there is evidence of community-based transmission. Monitoring surface waters used by 
drinking water distribution systems and receiving wastewater would be a secondary strategy, 
once resistant organisms are detected in wastewater. If carbapenem-resistant bacteria are found 
in the waste or source waters, the downstream drinking water intake plants should be monitored, 




modifiable to serve as a screen for carbapenem resistance in wastewaters. If carbapenem 
resistance cannot be readily identified in waste streams, then ESBL-producing bacteria could be 
monitored and modeled, as the spread of those organisms would mimic that of carbapenem-
resistant organisms.  
Antibiotic resistance is a public health emergency that requires immediate attention and 
will necessitate a manifold of solutions and interventions to preserve one of our greatest public 
health successes. Understanding the role of environmental transmission, particularly community 
acquisition of resistant organisms and resistance genes from drinking water, will be an essential 
component in the multipronged approach to solving the emergent and spreading antibiotic 
resistance crisis. 
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